You are currently viewing a new version of our website. To view the old version click .
Fishes
  • Review
  • Open Access

15 December 2025

Exploring NAD+ Biology in Fish: From Cellular Metabolism to Ecological Adaptations and Aquaculture Strategies

and
1
Immunobiology for Aquaculture Group, Department of Cell Biology and Histology, Faculty of Biology, University of Murcia, 30100 Murcia, Spain
2
Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Murcia, 30100 Murcia, Spain
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Feature Papers by Fishes’ Editorial Board Members

Abstract

This review elucidates the foundational principles of nicotinamide adenine dinucleotide (NAD+) homeostasis in humans, emphasizing its depletion during aging and in age-associated disorders. Subsequently, the discussion extends to NAD+ precursors and their potential therapeutic applications, with insights from research using zebrafish as a disease model. This information sheds light on the growing interest in NAD and its metabolism in the medical field and sparks curiosity among researchers focused on fish studies. The review further explores the role of nicotinamide in fish, encompassing core NAD+ metabolism, its participation in oxidative stress, environmental challenges, and the mitigation of pollutant-induced toxicity. Additionally, the implications of NAD+ in fish neurobiology, immune regulation, host–pathogen interactions, skin, eggs, and post mortem muscle were considered. Dietary modulation of NAD+ pathways to enhance growth, immunity, and product quality in aquaculture has also been highlighted. This review highlights the significance of NAD+ metabolism in fish biology, covering cellular energy production, physiological processes, and environmental adaptation, and proposes targeting NAD+-related pathways as a strategy for aquaculture and fish health management.
Key Contribution:
This review highlights the importance of nicotinamide in central NAD+ metabolism, which is essential for energy production and physiological function in fish. It emphasizes the role of NAD+ in nutrition, stress response, immune regulation, and neurobiology, and its potential to reduce the negative impacts of environmental pollutants and enhance fish quality. This study suggests that targeting NAD+ pathways may improve fish health and productivity in aquaculture.

1. Introduction

Nicotinamide adenine dinucleotide (NAD) was initially identified as a cofactor in yeast fermentation in 1906, originally termed ‘cozymase’. Its structure, consisting of adenine, phosphate, and a reducing sugar, was elucidated in the 1930s, and its function as a hydride transfer agent was clarified in 1936. NAD+ research was conducted using the three Nobel Prizes. Interest in NAD+ significantly increased in the early 2000s following its identification as a co-substrate for sirtuins (SIRTs), which are essential for regulating longevity and metabolism. NAD+ and NADH are indispensable for electron exchange reactions, particularly those mediated by oxidoreductases, which involve hydride transfer. NAD+ functions as an electron acceptor, whereas NADH serves as an electron donor and plays a vital role in catabolic pathways, such as glycolysis, fatty acid β-oxidation, and the tricarboxylic acid cycle. Currently, there is renewed scientific interest in NAD+, owing to its recently discovered role in regulating metabolism and longevity in humans [1]. This article presents a narrative review delineating the fundamental concepts of NAD+ homeostasis in humans. It subsequently examines evidence implicating NAD+ depletion during the aging process and various age-related disorders. This body of knowledge has prompted investigations into NAD+ precursors, their potential therapeutic value, and the effects of NAD+ in disease models using zebrafish. Finally, this review discusses the current state of research concerning studies conducted on fish, elucidating the relationships between NAD+ and related molecules and their most significant functions in these animals. The primary aim was to elucidate the fundamental concepts, evaluate various NAD+ boosters in aquafeeds and their bioavailability, perform comparative analyses to determine potential requirements for each fish species, and investigate optimal outcomes for the aquaculture industry.

2. Overview of NAD+ Biology and Its Balance in Human Health and Disease

The subcellular distribution of NAD+ and its biosynthetic enzymes varies across the cellular compartments. The nucleo-cytosolic NAD+ pool is considered to be interchangeable between cytosolic and nuclear pools, with similar concentrations in both [2]. The mitochondrial NAD+ pool, traditionally thought to be separated from the nucleo-cytosolic pool, may involve an unidentified mammalian mitochondrial NAD+ transporter [3]. Nicotinamide mononucleotide adenylyl transferase (NMNAT) is a non-histone chromatin-associated protein with distinct properties. NMNAT is distributed in the nucleus with specific binding affinities different from those of histones, suggesting its role in chromatin structure and nuclear processes, such as DNA repair [4]. Different NMNAT isoforms have distinct locations: NMNAT1 in the nucleus, NMNAT2 in the cytosol and Golgi, and NMNAT3 in mitochondria [5]. Consequently, variations in the subcellular distribution of NAD+ across tissues with distinct metabolic functions and requirements may be substantial. The allocation of NAD+ and its biosynthetic components within cellular compartments facilitates the regulation of NAD+-dependent processes in various cellular regions and tissues [1].
NAD can be synthesized via de novo and salvage pathways. De novo NAD+ synthesis occurs in the cytosol, where all enzymes are localized [2]. De novo synthesis begins with dietary tryptophan (Trp), whereas salvage pathways use vitamin B3 compounds like nicotinic acid (NA), nicotinamide (NAM), and nicotinamide riboside (NR) from the diet for NAD production. Both pathways could benefit aquaculture because fish diets can be supplemented to enhance NAD synthesis; however, these studies are still in their infancy. A review showed that the NAMPT-driven NAD+ salvage pathway supports muscle health by maintaining mitochondrial function, reducing oxidative stress, and promoting autophagy, muscle stem cell function, and neuromuscular junction integrity in aging and diseases [6]. These factors demonstrate the importance of NAD+ metabolism regulation through salvage pathway activation in combating metabolic, mitochondrial, neurotoxic, and muscle aging dysfunctions [6].
The main signaling pathways that consume NAD+ include SIRTs, poly (ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (cADPRSs). SIRTs are conserved NAD+-dependent deacetylases; therefore, their functions are intrinsically linked to cellular metabolism [7]. Localization varies across cellular compartments, potentially enabling compartment-specific regulation of NAD+ pools [8]. PARPs consume NAD+ and are involved in DNA repair and other cellular functions, whereas cADPRSs, specifically, CD38, are examples of enzymes that cleave NAD+ to generate secondary messengers involved in calcium signaling. These enzymes share the common property of irreversibly cleaving NAD+ into NAM and ADP-ribose moieties. They act as metabolic sensors and significantly influence organ metabolism, function, and aging [9].
Energy status influences NAD+ homeostasis in cells and organisms. Limited energy availability through caloric restriction, fasting, and exercise elevates NAD+ levels, while excessive energy consumption via high-fat or high-fat/sucrose diets depletes NAD+ in metabolic organs [10]. Circadian rhythms affect NAD+ levels and exhibit diurnal fluctuations in the liver. The circadian clock regulates NAD+ biosynthetic enzymes (e.g., NAMPT), whereas NAD+ consumers such as PARP-1, SIRT1, SIRT6, and SIRT3 regulate the circadian clock [11]. NAD+ levels oscillate circadianly through rhythmic expression of biosynthetic enzymes like NAMPT, while sirtuins (SIRT1, SIRT6) regulate clock components and circadian metabolic genes. Therapeutic approaches using chronopharmacology, NAD+ boosters, and SIRT modulators can restore circadian synchronization and improve age-related pathologies via the NAD+–sirtuin–clock network [12].
Strategies to enhance NAD+ synthesis include supplementation with NAD+ precursors (e.g., NAM, NA, NR, and NMN), stimulation of NAD+ synthesis enzymes (such as NAMPT), and activation of NAD(P)H-quinone oxidoreductase 1 (NQO1) [13,14]. To prevent NAD+ depletion, it is also possible to inhibit enzymes that consume NAD+ (e.g., SIRTs, PARP-1, and CD38) [15]. Additionally, the regulation of metabolic pathways is crucial, as it can divert metabolites from NAD+ production, and their inhibition may result in elevated NAD+ levels. Enzymes like nicotinamide N-methyltransferase (NNMT) facilitate NAM methylation using S-adenosyl methionine (SAM) as a methyl donor, producing 1-methylnicotinamide (MNAM) and S-adenosylhomocysteine [16]. Understanding these factors is crucial for formulating strategies to sustain NAD+ levels, which may be beneficial in age-related and metabolic diseases.

2.1. Reduction in NAD+ Levels Is Associated with Aging and Numerous Age-Related Diseases

NAD+ depletion is associated with aging and age-related disorders. Research in mammals shows that DNA damage from aberrant nutrition increases cellular NAD+ consumption. Lower NAD+ levels lead to oxidative stress and contribute to metabolic diseases [17]. NAD+ depletion is linked to neurodegenerative disorders (including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and prion diseases), all of which are characterized by protein misfolding and proteotoxic stress [18]. In addition, alcoholic and non-alcoholic fatty liver diseases are also associated with decreased NAD+ levels, as well as different cardiovascular diseases (including cardiac ischemia, cardiomyopathies, and cardiac hypertrophy) [19] and muscular disorders (e.g., muscular dystrophies, mitochondrial myopathies, and age-related sarcopenia). Enhanced NAD+ levels show promise in preserving muscle function in animal models [20] and kidney disorders, characterized by impaired mitochondrial function and reduced SIRT signaling [21]. In addition, maintenance of hepatic NAD+ content has shown protective effects against hepatic lipid accumulation and liver damage in various animal models [10]. Metabolic disorders like obesity and type 2 diabetes are associated with altered NAD+ homeostasis in tissues. Restoring NAD+ levels enhances mitochondrial function and shows protection in animal models, offering a promising therapeutic approach [10].

2.2. Potential Therapeutic Value of NAD+ Precursors

Owing to their significant bioactivity, directly supplying animals with exogenous NAD+ is challenging [17,22]. Vitamin B3 (NA and NAM) and derivatives like NR and NMN are NAD+ precursor vitamins [23,24]. The administration of NAD+ donors can elevate NAD+ concentrations within cells, thereby ameliorating metabolic dysfunction. Research shows these NAD+ precursors have distinct effects due to their unique properties in enhancing NAD+ levels in mammalian cells [17,25]. For instance, oral administration of NR enhances hepatic NAD+ levels in mice more effectively than NA or NAM [26]. A review has evaluated NMN and NR as NAD+-boosting precursors. Both compounds increase NAD+ levels and benefit aging- and metabolism-related health. Studies suggest NR may increase NAD+ more efficiently, as NMN needs conversion to NR before cellular uptake. Animal studies also show NMN has superior effects in specific contexts [27]. These findings indicate NAD+ enhancement’s potential advantages for age-related and metabolic disorders in humans. Although preclinical research shows promise, clinical evidence remains early [27]. Most human studies conducted to date have been short-term, spanning weeks to months. There is a notable lack of data regarding long-term NAD+ supplementation in humans. Consequently, further research involving long-term clinical trials with larger cohorts is necessary to fully comprehend the therapeutic potential of NAD+ [1,28]. Studies have shown that NAD+ precursors such as NR are well tolerated by humans over short periods [29]. Research indicates that the effects of NAD+ supplementation vary, with individual differences influenced by factors such as age, health status, and metabolic conditions. Therefore, caution must be exercised in this context. Clinical trials are essential for assessing the effects and risks of NAD+ supplementation in humans. Further research is needed to identify adverse effects and confirm long-term supplementation safety. These considerations highlight the importance of trials in mitigating risks of unregulated NAD+ boosters [1].
Promising results from NAD+ supplementation suggest its potential application in oncology and anti-aging therapies. A hopeful treatment strategy demonstrates NR’s effectiveness alongside other components while maintaining radiotherapy efficacy in tumor xenograft models. Combined treatment with polyphenols, pterostilbene, silibinin, NR, and TLR2/6 ligand (FSL-1) provided radioprotection in mice exposed to lethal γ-radiation. While polyphenols alone enabled 30-day survival, the complete combination provided 90% survival at one year post-irradiation. Protection mechanisms involve Nrf2-mediated antioxidant responses, DNA repair through PARP1, NF-κB inflammation suppression, mitochondrial stabilization via PGC-1α/SIRT1/SIRT3, and accelerated hematopoietic recovery [30]. However, the geroscience hypothesis posits that addressing the core elements of aging could prevent age-related diseases and prolong healthy life. Research has explored interventions including senolytics, NAD+ enhancers, and metformin. NAD+ enhancement using NMN and NR precursors increases the health span of model organisms, although human results vary [31]. Clinical trials in older adults and obese individuals show its safety and improvements in insulin sensitivity and aerobic capacity. While NMN and NR are promising NAD+ precursors, NR shows high bioavailability [32]. Current research has indicated that these agents have the potential to improve health. Nevertheless, further studies are required to conduct clinical comparisons and ascertain optimal dosages, benefits, and safety profiles.

3. Zebrafish (Danio rerio) Models for Exploring NAD+-Related Pathways in Humans

Given the conservation of metabolic pathways across animal species, research on lower animals provides insights into human metabolic diseases [33]. Studies have shown similar pathophysiological pathways in metabolic diseases in mammalian and fish models [34,35,36]. In addition, fish are reliable and cost-effective experimental alternatives to mammals [37,38]. Therefore, the function of NAD+ in disease models has been extensively investigated using zebrafish as a model organism. This review chronologically presents available studies and their principal findings, showing the progress of research in this field.
Nrk2b, a nicotinamide riboside kinase in zebrafish muscle, is essential for muscle morphogenesis by regulating NAD+-dependent cell–matrix adhesion at the myotendinous junction (MTJ). Nrk2b-mediated NAD+ biosynthesis enables laminin polymerization. In Nrk2b-deficient embryos, muscle fibers extend beyond the somite boundaries. NAD+ rescues MTJ morphology in Nrk2b morphants but not in laminin mutants. Both Nrk2b and laminin control paxillin localization to adhesion complexes. Paxillin overexpression restores MTJ integrity in Nrk2b-deficient embryos, revealing an essential Nrk2b → NAD+ → laminin adhesion → paxillin localization pathway for muscle boundary formation [39]. Increasing NAD+ levels via supplementation or Nrk2b-mediated biosynthesis improves muscular dystrophy in zebrafish lacking laminin-binding complexes. Boosting NAD+ restores basement membrane organization through laminin polymerization, improving locomotor performance. Paxillin overexpression partially rescued muscle structure but not motility. An Nrk2b → NAD+ → laminin → integrin α6/paxillin pathway enhances muscle-ECM resilience, suggesting potential therapy for muscular dystrophy [40]. NAD+ supplementation improved muscular dystrophy pathology in zebrafish with Duchenne muscular dystrophy by restoring NAD+ homeostasis. The study linked muscle damage to NAD+ depletion, which impaired mitochondrial function and SIRT1-mediated responses. NAD+ administration enhanced SIRT1 activation and muscle membrane stability, identifying NAD+ biosynthesis as a therapeutic target for DMD through metabolic–epigenetic crosstalk [41].
Numerous studies have focused on mitigating the adverse effects associated with various diseases through the restoration of NAD+ levels using different methodologies. Resveratrol reduces hepatic lipid accumulation and improves lipid profiles by upregulating fatty acid oxidation genes. SIRT1 activation enhances mitochondrial function and insulin sensitivity through the NAD+–sirtuin pathway. Resveratrol counteracts diet-induced dysregulation of lipid metabolism in zebrafish via NAD+-dependent SIRT1 signaling [42]. Chronic ethanol exposure induces hepatic steatosis and inflammation in zebrafish, similar to alcoholic liver disease in mammals. Ethanol treatment caused lipid accumulation and increased inflammatory markers, indicating liver injury. These effects correlate with ethanol-induced suppression of NAD+-dependent SIRT1 activity, which regulates metabolism and inflammation. Zebrafish thus serve as a model for studying alcoholic liver disease and NAD+-targeting therapies [43]. Adult zebrafish exposed to 0.5% ethanol showed elevated serum ALT levels at 48–72 h, with increased hepatic pro-inflammatory and lipogenic gene expression, indicating liver injury. Drug trials showed nicotinamide riboside TES1025 (an inhibitor of amino-β-carboxymuconate-ε-semialdehyde decarboxylase in the tryptophan–kynurenine–NAD+ pathway) and riboflavin suppressed ethanol-induced ALT elevation. The model revealed mechanisms including oxidative stress via ROS, NF-κB-mediated inflammation, and steatosis, while ethanol metabolism impairs antioxidant defenses. N-acetylcysteine and silymarin attenuated injury by suppressing ROS/NF-κB and restoring AMPK-mediated lipid metabolism, validating adult zebrafish as a platform for testing hepatoprotective agents against ethanol toxicity [44].
NAMPT, the rate-limiting enzyme in NAD+ salvage, drives PARP1 hyperactivation and cell death, promoting inflammation in zebrafish and human skin models. Inhibition of NAMPT, PARP1, and NADPH oxidases reduced oxidative stress and cell death. NAD+ supplementation reversed these protective effects, confirming NAMPT-NAD+’s role in inflammatory pathology. Elevated NAMPT and PARP1 activities with AIM1 nuclear translocation in psoriatic skin highlight this pathway as a therapeutic target [45].
Propionate induces intestinal oxidative stress in zebrafish through NAD+-dependent SIRT3-regulated propionylation of mitochondrial SOD2. Propionate exposure causes metabolic dysregulation via impaired NAD+/SIRT3 signaling, leading to SOD2 hyperpropionylation and inactivation, revealing how propionate induces oxidative stress despite benefiting gut health [46]. A dietary formulation of NMN with astaxanthin and blood orange extract (NOA) was studied in aging zebrafish. NOA showed superior NAD+ bioavailability in vivo. Treated fish demonstrated reduced aging, enhanced activity, improved sleep, better skin health, and increased ATP synthesis, indicating NOA’s anti-aging benefits [47]. Further research is required to elucidate the established connections between microbial metabolites, post-translational modifications, and redox homeostasis in vertebrates.
Exposure of zebrafish larvae to decabromodiphenyl ethane (DBDPE) induces insulin resistance, lipid accumulation, and neurotoxicity through acetylcholinesterase inhibition and mitochondrial dysfunction, reducing oxidative phosphorylation and ATP production. NR reversed these effects [48]. Aspartame causes developmental defects in zebrafish embryos by disrupting NAD+-dependent SIRT1/FOXO3a signaling, reducing NAD+ levels, and causing neuronal apoptosis. These findings showed the NAD+/SIRT1/FOXO3a pathway’s role in neurodevelopment and demonstrated how artificial sweeteners affect development, suggesting NAD+ homeostasis may mitigate aspartame-induced neurotoxicity [49]. Recently, a zebrafish model was established for Congenital NAD+ deficiency disorders (CNDD), showing developmental anomalies similar to human CNDD and vertebral–anal–cardiac–tracheoesophageal fistula–renal–limb (VACTERL) association syndrome. 2-amino-1,3,4 thiadiazole (ATDA)-induced neural tube defects, craniofacial malformations, and cardiac abnormalities were rescued by NAM supplementation, confirming the role of NAD+ depletion. These results demonstrated that zebrafish are useful for studying NAD+-dependent malformations and investigating CNDD and VACTERL phenotypes in vivo [50].
Perfluorooctanoic acid (PFOA), used in Gore-Tex and Teflon manufacturing, causes premature ovarian insufficiency in female zebrafish, reducing spawning and increasing embryo mortality. PFOA suppresses NAD+ biosynthesis and impairs mitochondrial integrity in oocytes, with NMN supplementation alleviating reproductive defects by restoring NAD+ levels. These findings suggest NMN as a potential therapeutic for chemical disorders in zebrafish gonads [51]. Another work on the PRPS1 variant in X-linked hearing loss revealed its connection to NAD+ homeostasis. PRPS1 catalyzes purine nucleotide synthesis for the NAD+ salvage pathway, with its Ser115Gly variant impairing GTP/ATP production, potentially disrupting NAD+ levels and NAD+-dependent processes [52].
Other studies have also focused on emulating diseases affecting the nervous system. NR significantly prolonged survival and improved motor function in a zebrafish model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease. Transcriptomic and metabolomic analyses revealed that NR exerts neuroprotective effects by downregulating gluconeogenic enzymes and upregulating glycolytic enzymes, while attenuating endoplasmic reticulum (ER) stress, providing mechanistic insights into potential therapeutic approaches for Parkinson’s [53]. Zebrafish models of TANK-binding kinase 1 (TBK1, a serine/threonine kinase that is constitutively expressed and involved in various cellular processes, including innate immunity and autophagy) deficiency showed that TBK1 loss causes motor neuron degeneration and impaired swimming. Metabolomics revealed that TBK1 disruption leads to NAM pathway dysregulation and NAD+ depletion, with NR supplementation rescuing the motor function. Proteomic analysis showed elevated inflammatory markers and necroptosis, the inhibition of which improved survival [54].
These studies highlight the efficacy of zebrafish as a model organism for investigating proposed diseases. Furthermore, they emphasize that a comprehensive understanding of NAD+ metabolism in vertebrates, both generally and in specific species of interest, can enhance our comprehension of prevalent pathologies affecting these organisms. Additionally, it is of interest to explore methods to augment NAD+ reserves, which appear to be consistently depleted or exhausted during these pathological processes.

5. NAD+ Metabolism and Neuromodulation in Fish: From Muscle Innervation to Cognitive Function

The main results of this topic are summarized in Table 4. The presence of different putative neuromodulators in the nerves innervating the skeletal muscles of teleosts has been previously investigated. Morphological investigation involved histochemical staining of cryostat sections from the epaxial, hypaxial, and adductor mandibulae muscles of the gilthead seabream and eel (Anguilla anguilla) to reduce NADPH-diaphorase activity. This study links NAD metabolism to neuromodulation, as NADPH-diaphorase enzymes produce nitric oxide (NO), with NADPH serving as a cofactor in fish muscle function modulation [117].
Table 4. NAD metabolism and neuromodulation in fish.
Table 4. NAD metabolism and neuromodulation in fish.
Species/ModelFocus/PathwayNAD+/NADPH RoleMain FindingsReferences
Gilthead seabream
(Sparus aurata), and eel
(Anguilla anguilla)
Neuromodulators and NADPH-diaphoraseNADPH as a cofactor for nitric oxide (NO) productionHistochemical staining revealed NADPH-diaphorase activity in skeletal muscle nerves, linking NAD metabolism to NO-mediated neuromodulation of muscle function.[117]
General vertebrate modelcAMP Response Element-Binding Protein (CREB) transcription factorIndirect NAD+/SIRT1 (sirtuin 1) regulationCREB integrates extracellular signals into gene expression changes, regulating survival, metabolism, and circadian rhythms.[118]
Goldfish
(Carassius auratus)
CREB in learning and memoryNAD+-SIRT1 regulation of CREBCognitive activity triggers CREB phosphorylation in memory-related brain areas; NAD+-SIRT1 likely modulates CREB-dependent plasticity.[119]
GoldfishmiRNA-132/212 and fear memoryNAD+ in neuroplasticity and epigeneticsmiRNAs regulate neuronal plasticity; altered NAD+ metabolism may affect memory formation and synaptic function.[120]
Mediterranean farmed fishSomatotropic axis and growth regulationNAD+/SIRT1 metabolic regulationNutrition and environment modulate hepatic sirtuin activity; diet enhances NAD+-SIRT1 signaling, stress impairs growth via metabolic disruption.[121]
Swordtail fish (Xiphophorus helleri)NADPH-diaphorase atlas and escape reflexNADPH as NOS cofactorMapped NADPH-d in Mauthner cells; linked NADPH-dependent NO signaling to escape reflex pathways.[122]
Dogfish
(Triakis scyllia)
Vagal afferent NADPH-d activityNADPH in sensory NO signalingNADPH-d in vagal afferents suggests NADPH-dependent NO production in sensory/autonomic pathways.[123]
Cichlid
(Tilapia mariae)
NADPH-d in the central nervous systemNADPH in neural developmentHistochemistry showed NADPH-d activity essential for NO-mediated maturation of neuronal pathways.[124]
African cichlid (Haplochromis burtoni)Brain regional NADPH-d mappingNADPH turnover from NAD+Enrichment in the entopeduncular nucleus suggests localized NAD+/NADP+ demand for NO signaling.[125]
Goldfish
(Carassius auratus)
Nitric oxide synthase (NOS) and NADPH-d distributionNADPH as a cofactor for NOBroad distribution in brain regions for sensory, motor, and neuroendocrine regulation.[126]
Grass puffer (Takifugu niphobles)NOS in the branchial innervationNADPH-dependent (NOS) activityNOS activity in glossopharyngeal/vagal afferents links NAD+ metabolism to vascular regulation in gills.[127]
Atlantic salmon (Salmo salar)NAD+ in acoustic stress responseNAD+/NADH redox in auditory stressGenes linked to NAD+ metabolism and oxidative stress protect auditory tissues from loud sound damage.[128]
The cAMP Response Element-Binding Protein (CREB) functions as a transcription factor. It converts external signals into lasting gene expression changes within the cell nucleus, activating genes for learning, memory, survival, metabolism, and circadian rhythms [118]. CREB signaling in spatial learning and memory was explored in goldfish, showing that cognitive activities trigger CREB phosphorylation in brain areas linked to learning. Although it does not directly address NAD+ or SIRTs, CREB activation is associated with NAD+-dependent SIRT1 regulation in vertebrates. These results suggest that goldfish use conserved mechanisms of spatial cognition, including sirtuin-mediated regulation. These findings provide insights into fish neurobiology and metabolic effects on cognition across species [119]. In goldfish, spatial learning has been studied regarding CREB signaling activation. CREB is crucial for memory formation and synaptic plasticity. NAD acts as a cofactor for sirtuins (SIRT1), which modulate CREB activity in learning and memory. NAD-dependent pathways may influence CREB activation during spatial learning [119]. Changes in microRNA-132/212 expression affect fear memory. NAD+ metabolism, which supports neuronal homeostasis and sirtuin-mediated regulation, could intersect with miRNA processes influencing memory. Altered NAD+ levels may affect synaptic function and neuroprotective mechanisms [120].
The regulatory mechanisms of the somatotropic axis in Mediterranean marine farmed fish were investigated, demonstrating that nutritional and environmental factors modulate growth through NAD+-sensitive metabolic pathways. Dietary and environmental stressors alter hepatic SIRT activity and NAD+ bioavailability, thereby influencing growth hormone signaling and energy allocation. Optimal nutrition enhances NAD+/SIRT1 signaling and metabolic efficiency, but environmental challenges disrupt this pathway, causing growth retardation. These findings reveal the link between nutrient sensing and endocrine growth regulation in fish, informing aquaculture optimization through metabolic targeting [121].
NADPH-diaphorase (NADPH-d) activity, linked to nitric oxide (NO) signaling, has been mapped in fish species, showing NAD-related cofactors’ role in neural function and sensory processing. A detailed atlas of NADPH-d activity in swordtail fish (Xiphophorus helleri) brains was developed. This enzyme has been studied in Mauthner cells involved in fish escape reflexes. NADPH-d marks nitric oxide synthase (NOS), which produces NO from L-arginine, linking NADPH activity to brain escape responses and NO-mediated neurotransmission [122]. NADPH-d activity was studied in the vagal afferent pathway of dogfish (Triakis scyllia) and suggests that NADPH-dependent NO production plays a significant role in neural signaling within this sensory pathway. This highlights the importance of NADPH in modulating neural functions related to autonomic control via NO synthesis [123]. NADPH-d activity was investigated in the central nervous system of cichlid fish (Tilapia mariae). These results demonstrated the importance of NADPH in the maturation and functioning of neuronal pathways in fish, emphasizing its critical role in NO-mediated neurodevelopment and neural communication [124]. Another histochemical study mapped NADPH-d activity in the brains of African cichlid fish (Haplochromis burtoni), with notable enrichment in the entopeduncular nucleus. NADPH is generated from NADP+, which is ultimately derived from NAD+ via phosphorylation, indicating that these patterns reflect the localized metabolic demand for NAD+-derived cofactors. These results suggest that specific brain regions have elevated NAD+/NADP+ turnover to sustain NO signaling, highlighting the integration of redox cofactor metabolism with neuromodulatory functions in teleosts [125]. NADPH-diaphorase activity and NOS reactivity were analyzed in the goldfish central nervous system. NADPH-diaphorase, reflecting NOS activity, is distributed across brain regions controlling sensory processing, motor function, and neuroendocrine regulation, highlighting NADPH’s role as a cofactor in NO production, a key neuromodulator in teleost brain functions [126]. On the other hand, NOS was studied in the glossopharyngeal and vagal afferent pathways of the grass puffer (Takifugu niphobles), focusing on branchial vascular innervation. NAD metabolism was linked directly to NO signaling pathways in fish, stressing the role of NADPH-dependent NOS activity in regulating vascular function and neural signaling in teleost gills [127]. Another study underscored NAD’s critical role in cellular resilience and neuroprotection of fish exposed to acoustic stress. A specific gene set was identified in the ears of fish, using Atlantic salmon (Salmo salar) as a model to assess the potential impact of loud sounds, such as those from seismic surveys. Research has focused on genes involved in auditory function, stress responses, and cellular repair mechanisms. Among these, genes related to NAD+/NADH-dependent processes and oxidative stress pathways have been identified, reflecting the importance of redox balance and energy metabolism in protecting auditory tissues from sound-induced damage [128]. Given the unique sensory characteristics of marine fish and the vast diversity of species, further research on the effects of NAD+ metabolism on these sensory systems and their relationship with the central nervous system is recommended.

6. Dietary Interventions and NAD+ Homeostasis: Implications for Fish Health and Product Quality

Numerous in vivo assays have been developed for fish, in which the diet is enriched with a variety of compounds. In this review, we focus on studies utilizing biologically active compounds that are essential for metabolic processes. These compounds are involved in biochemical pathways including energy production, tissue repair, and cellular regulation, highlighting their importance in nutrition and physiological functions. Interestingly, there is a scarcity of studies on this subject that have examined the role of NAD+ and its associated metabolites (Table 5).
The tissue-specific expression and nutritional regulation of SIRT genes (SIRT1–7) were elucidated in gilthead seabream, revealing that fasting significantly upregulates hepatic SIRT1 and SIRT3 expression, highlighting their NAD+-dependent roles in metabolic adaptation to nutrient deprivation. These findings demonstrate conserved yet specialized SIRT functions across tissues, with SIRT1/SIRT3 dominating in metabolically active organs (liver and muscle) and SIRT2 dominating in the brain, while identifying teleost-specific gene duplications (SIRT3 and SIRT5), suggesting potential subfunctionalization. These results provide critical insights into how sirtuins orchestrate energy homeostasis in marine fish through NAD+-sensitive pathways, thereby establishing an evolutionary framework for understanding metabolic stress responses in aquatic vertebrates [129].
Another study demonstrated that dietary supplementation with mulberry leaf meal enhanced the growth performance and immune function of juvenile Wuchang bream by modulating key metabolic and immune pathways, including the potential activation of NAD+-dependent processes. The findings revealed that mulberry leaf inclusion (optimal at 6–9% of diet) significantly improved growth rate, feed utilization, and antioxidant capacity, while upregulating immune-related genes (e.g., TNF-α and IL-1β) and intestinal barrier function, suggesting its role as a functional feed additive that may influence SIRT-mediated metabolic regulation. These results highlight the potential of phytogenic feed supplements to enhance aquaculture productivity through multi-targeted effects on fish physiology, possibly involving NAD+-sensitive pathways that link nutrition with immune–metabolic homeostasis [130].
Dietary modulation of NAD+ precursors and related metabolic pathways influences fish growth, product quality, and disease resistance. For example, the delivery of chitosan-tripolyphosphate-DNA nanoparticles expressing the transcription factor SREBP1a enhanced the conversion of dietary carbohydrates into lipids in the liver of gilthead seabream. Although NAD was not explicitly mentioned in the study, it is likely to be involved in this metabolic shift because NAD+/NADH is a crucial cofactor in carbohydrate metabolism and lipid biosynthesis. Increased lipogenesis driven by SREBP1a expression would require NADPH as the key reducing agent for fatty acid synthesis. Therefore, modulation of NADPH-dependent pathways is central to the enhanced lipid production observed following nanoparticle-mediated gene expression in fish livers [131]. Dietary supplementation with branched-chain amino acids (BCAAs), leucine, and valine enhances growth performance, glycolipid metabolism, and immune function in genetically improved farmed tilapia (GIFT, O. niloticus), potentially via the NAD+-sirtuin pathway. These findings show that BCAAs improve hepatic insulin sensitivity and antioxidant capacity while reducing inflammation, which is associated with SIRT1/AMPK activation. Optimal BCAA ratios enhance nutrient utilization and disease resistance, suggesting their role in metabolic–immune homeostasis via NAD+-dependent regulatory networks. These results provide dietary guidelines for tilapia aquaculture and suggest associations between amino acid metabolism and SIRT-mediated regulation in teleosts [132]. Niacin (vitamin B3) deficiency in grass carp results in poor flesh quality and is associated with metabolic disruptions. Niacin is a precursor of NAD+ and NADP+, which are essential cofactors in cellular metabolism. Deficiency causes increased glycolysis and mitochondrial dysfunction, reflecting an imbalance between the NAD+/NADH ratio and energy homeostasis. This highlights the crucial role of NAD biosynthesis in fish health, growth, and product quality [133]. In a study that primarily analyzed the nutritional composition of fish by-products [head, gills, intestines, trimmings, bones, and skin from meagre (Argyrosomus regius) and gilthead seabream], the findings have indirect implications for NAD+ metabolism. The by-products were rich in niacin (vitamin B3) precursors, amino acids such as tryptophan, and high-quality proteins, all of which contribute to NAD+ biosynthesis through the de novo and salvage pathways. The utilization of such by-products in aquafeeds or functional foods could help sustain NAD+ levels in fish and humans, supporting metabolic health, oxidative stress resistance, and cellular energy production [134].
Wuchang bream is a cyprinid fish with a significant commercial value [34]. Owing to its herbivorous diet, this species is susceptible to hepatocyte injury induced by high glucose levels, which is a consequence of consuming high-carbohydrate diets [135]. Notably, NAD+ depletion has been observed in individuals of this species who experience hyperglycemia [136]. Consequently, M. amblycephala serves as an appropriate model for studying liver damage induced by high glucose levels. In light of these considerations, one study investigated the protective effects of four NAD+ precursors (NA, NAM, NR, and NMN) against high-glucose-induced hepatocyte damage in this fish species. NR was the most effective in restoring NAD+ homeostasis, activating Sirt1/Sirt3, reducing oxidative stress and inflammation, and improving glucose metabolism both in vitro and in vivo. NR and NMN were particularly effective in improving glucose metabolism, suggesting their therapeutic potential for mitigating hyperglycemia-related liver damage. These findings highlight NAD+ supplementation as a promising strategy for addressing diabetes-related hepatic dysfunction [137]. However, the efficacy of NAD+ precursors for the treatment of metabolic disorders remains unclear. A comparison of NAD+ precursors focused on their effectiveness in reducing high glucose-induced hepatocyte damage. Each precursor has distinct properties that affect the NAD+ levels and pathway activation. Identifying the most effective precursor (NR) can help develop strategies to combat metabolic dysfunctions. This study identified NR as the most potent precursor for protecting hepatocytes and improving metabolic health.
Another popular topic in aquaculture is the use of alternative sources of protein in aquatic feed derived from agricultural waste, which can reduce the feed production costs in developing areas. Agricultural waste is used to raise insects for dry meal production in animal feed and human consumption [138]. Zophobas atratus Fab. (superworms) from the order Coleoptera and family Pyrethidae serve as food and feed sources [139]. Z. atratus grows faster and adapts better than Tenebrio molitor L. [140]. Z. atratus larval meal (ZLM) can improve fish growth and meat quality, though its metabolic effects are understudied. Although tilapia production has increased through factory farming, consumer focus has shifted from quantity to quality, emphasizing fish meat flavors [141]. One study examined how ZLM improved the flavor of tilapia meat. Soybean meal in the basal diet was replaced with 15, 30, or 60% ZLM. After 30 days, the dorsal muscles of tilapia underwent sensory evaluation, whereas the liver samples were subjected to metabolomic analysis. ZLM enhanced liver energy metabolism enzymes, including NADP-malate dehydrogenase (NAD-MDH), increasing NADH, acetyl-CoA, and ATP levels, leading to fatty acid accumulation. Flavor nucleotides and umami metabolites increased, whereas off-flavor metabolites decreased. This study showed that ZLM diets enhanced tilapia muscle flavor by reducing earthy taste and increasing flavor compounds, thereby improving meat quality [142].
In a recent study, replacing fishmeal with Spirulina platensis affected the liver of a zig-zag eel (Mastacembelus armatus) infected with A. hydrophila. NAD is likely involved here because liver metabolic and immune responses depend heavily on the redox balance and energy metabolism, both of which are regulated by NAD/NADH and NADP/NADPH pools. Spirulina is known for its antioxidant and immunomodulatory properties, which can influence NAD-dependent enzymes (e.g., SIRTs and PARPs) involved in the oxidative stress response and inflammation. Thus, dietary Spirulina may modulate NAD-related pathways in the eel liver, enhancing resistance to bacterial infection and supporting liver function during immune challenges [143].
As mentioned in this review, several studies have reported the use of resveratrol as a dietary supplement in fish. Resveratrol attenuates the senescence-associated secretory phenotype (SASP) in the gut of Günther’s killifish (Nothobranchius guentheri) through activation of the NAD+-dependent SIRT1/NF-κB pathway. Resveratrol treatment reduced age-related inflammation by enhancing SIRT1-mediated deacetylation, suppressing NF-κB signaling, and decreasing pro-inflammatory cytokine production. These results highlight the role of the NAD+/SIRT1 axis in modulating gut senescence, and suggest that SIRT1 activation may counteract age-related gut dysfunction. This study provides insights into the mechanisms linking SIRT activity, inflammation, and aging in vertebrates, supporting the potential of NAD+-boosting compounds in age-related diseases [144]. Resveratrol supplementation improved hepatic lipid metabolism in red tilapia by activating NAD+/SIRT1/AMPK signaling, enhancing lipolysis, and suppressing lipogenesis. The results showed that resveratrol reduced hepatic lipid accumulation by upregulating fatty acid oxidation genes (e.g., PPARα) and downregulating adipogenic markers through SIRT1-dependent deacetylation. These findings highlight the potential of resveratrol in managing hepatic steatosis in aquaculture species by modulating NAD+-sensing pathways that regulate energy homeostasis, thereby providing insights into polyphenol-mediated metabolic reprogramming in teleost fish [145]. In addition, resveratrol significantly delayed ovarian aging in short-lived Günther’s killifish by alleviating inflammation and ER stress through the SIRT1/NRF2 signaling pathway. These findings reveal that the anti-aging effects of resveratrol are mediated by SIRT1, an NAD+-dependent deacetylase that enhances antioxidant defenses. Resveratrol mitigates age-related ovarian dysfunction and preserves follicular integrity by boosting NAD+ levels and SIRT1 activity. These results highlight the role of NAD+/SIRT1 signaling in combating ovarian aging and suggest resveratrol as a promising therapeutic agent for age-related reproductive decline. This study provides insights into the mechanisms linking NAD+ metabolism and ovarian senescence [146].
The optimal dietary level of ARA (an omega-6 fatty acid involved in inflammation) in black seabream was found to be 0.76% of dry weight, underscoring its role in regulating growth and lipid metabolism through the NAD+-sirtuin pathways. ARA supplementation enhances growth and hepatic lipid homeostasis by promoting fatty acid oxidation (PPARα) and inhibiting lipogenesis, aligning with SIRT1 activation. The anti-steatotic effects of ARA were linked to improved mitochondrial function and reduced oxidative stress, suggesting an interaction between NAD+-dependent regulation and eicosanoid signaling. These findings provide dietary guidelines and indicate that ARA may optimize NAD+/SIRT1 signaling for metabolic flexibility in marine fish [147]. A recent study investigated the effects of dietary supplementation of menadione nicotinamide bisulfite (VK3) on Coho salmon alevins. VK3 is a synthetic form of vitamin K3 that integrates vitamin K3 with nicotinamide. The nicotinamide component supports the redox balance and energy metabolism through the NAD+ salvage pathway. The findings showed that Optimal VK3 levels improved growth performance, antioxidant capacity, and tissue composition, indicating that dietary nicotinamide enhances NAD+-dependent processes essential for early fish development [148].
Table 5. Modulation of NAD+ pathways in fish through the use of dietary supplements to improve growth, immunity, and product quality.
Table 5. Modulation of NAD+ pathways in fish through the use of dietary supplements to improve growth, immunity, and product quality.
Fish SpeciesSupplements/ContextAssay ConditionsKey FindingsReferences
Gilthead Seabream
(Sparus aurata)
Sirtuins (SIRTs), genes, and fasting10-day fasted fishFasting upregulated hepatic sirt1/sirt3, showing NAD+-dependent roles in nutrient deprivation. SIRT functions tissue-specific[129]
Wuchang bream (Megalobrama amblycephala)Mulberry leaf meal (ML) and fermented ML
(FML)
2.22% and 4.44% of ML or FML for 8 weeksDietary supplementation (6–9%) enhanced growth, feed efficiency, antioxidant capacity, and immune genes.[130]
Gilthead seabreamIsoenergetic diets differing in protein-to-carbohydrate ratio and chitosan-tripolyphosphate-DNA nanoparticles 40 g/kg body weight for 15 days.
The nanoparticles were intraperitoneally injected
Gene delivery enhanced carbohydrate-to-lipid conversion; NAD+/NADH and NADPH are involved in lipogenesis.[131]
Tilapia GIFT (Oreochromis niloticus)Branched-chain amino acids (BCAA) supplementation (Leu, leucine, and Val, valine)Four diets containing two Leu levels
(1.2% and 2.3%) and
two Val levels
(0.7% and 1.4%)
Leucine/valine enhanced growth, glycolipid metabolism, and immune function. Improved insulin sensitivity, antioxidant capacity, and disease resistance.[132]
Grass carp (Ctenopharyngodon idella)Niacin
(vitamin) deficiency
0.49, 9.30, 21.30, 33.30, 45.30, and 57.30 mg/kg of dietDeficiency caused poor flesh quality, increased glycolysis, and mitochondrial dysfunction. [133]
Meagre (Argyrosomus regius) and
gilthead seabream
Fish by-productsHead, gills, intestines, trimmings, bones, and skin were reared in GreeceBy-products rich in niacin, tryptophan, and proteins—contribute to NAD+ biosynthesis via de novo/salvage pathways.[134]
Wuchang breamNAD+ precursors (hyperglycemia)10 and 50 μM in the cell culture mediaNA, NAM, NR, NMN tested against high-glucose damage. NR most effective: restored NAD+.[137]
Nile tilapia (Oreochromis niloticus)Zophobas atratus larval (ZLM) mealSoybean meal in the basal diet was replaced with 15%, 30%, or 60% ZLM, and anti-nutrient factors were destroyed by high-temperature treatmentImproved flavor quality and energy metabolism. Increased umami compounds, reduced off-flavors[142]
Zig-zag eel
(Mastacembelus armatus)
Spirulina supplementation and Aeromonas hydrophila infection0, 5%,10%, 15%, 20%, 25% was used to replace fishmealImproved liver immune/metabolic responses under infection, regulating oxidative stress and inflammation[143]
Killifish
(Nothobranchius guentheri)
Resveratrol (antioxidant) in reproductive aging200 μg/g food for 6, 9, and 12 monthsReduced inflammation, improved lipid metabolism, and delayed ovarian aging. SIRT1 has a role in gut senescence, hepatic steatosis, and reproduction[144]
Nile tilapiaResveratrol
(RES)
and EX527
(a selective inhibitor of Sirtuin 1)
8% fat; 10% high fat (HF); 10% fat + 0.02 g/kg RES 10% HF + RES;
10% fat + 0.02 g/kg RES + 5 mM EX527
Improved hepatic lipid metabolism by enhancing lipolysis and suppressing lipogenesis[145]
KillifishResveratrol in short-lived fish200 μg/g food for
6, 9, and 12 months
Delayed ovarian aging[146]
Black seabream (Acanthopagrus schlegelii)Arachidonic acid0.1, 0.59, 1.04, 1.42, 1.94, and 2.42% of the feed for 8 weeksAn optimal 0.76% diet improved growth and lipid metabolism via SIRT1 activation. Promoted FA oxidation, reduced lipogenesis/oxidative stress[147]
Coho salmon (Oncorhynchus kisutch)Vitamin K3 + nicotinamide 0.16 (control), 5.25, 10.22, 14.93, 20.51, 40.09, and 59.87 mg/kg of dietImproved growth, antioxidant capacity, tissue composition. Nicotinamide component supports the NAD+ salvage pathway and redox balance[148]

8. NAD+ Metabolism in Fish: Implications for Immune Defense and Cellular Homeostasis

NAD+-related metabolic pathways were found to be significantly altered during bacterial and parasitic infections, underscoring their roles in orchestrating immune defenses and maintaining cellular homeostasis (Table 7). Metabolomic profiling was used to explore the inflammatory and oxidative stress responses in common coral trout (Plectropomus leopardus) infected with Vibrio sp. Key findings indicated significant alterations in NAD+-dependent metabolic pathways, including shifts in the redox balance and energy metabolism. The modulation of NAD+-linked enzymes and cofactors under infection stress suggests that NAD+ metabolism plays a central role in orchestrating immune defense and maintaining cellular homeostasis during bacterial challenge [156].
Aptamers are artificial single-stranded oligonucleotide molecules that bind to specific target molecules with a high affinity and specificity [157]. Aptamers are widely utilized in various fields, such as disease diagnosis and treatment, analysis and detection, and targeted therapy [158]. Transcriptomic approximations were used to determine how aptamer B4 inhibited Pseudomonas plecoglossicida (a fish pathogen). While this work mainly focuses on antibacterial mechanisms, transcriptomic shifts likely involve metabolic pathways, including NAD+/NADH redox reactions, which are key to bacterial energy metabolism and stress responses. Understanding these pathways could reveal targets in NAD-dependent processes for therapeutic intervention [159].
A mechanism by which interferon regulatory factor 9 (IRF9) promotes apoptosis and enhances innate immunity in grass carp by suppressing the SIRT1–p53 axis was revealed. IRF9 directly inhibited SIRT1 activity, leading to increased p53 acetylation and apoptosis during viral infection, thereby strengthening the antiviral response. This study showed an evolutionarily conserved trade-off between metabolic regulation and immune defense, providing evidence that IRF9 prioritizes immune activation over cellular survival. These results advance our understanding of immunity and NAD+-mediated metabolic regulation in vertebrates, with implications for immunostimulatory strategies in aquaculture [160].
Metformin is a first-line therapy for the treatment of type 2 diabetes, due to its robust glucose-lowering effects, well-established safety profile, and relatively low cost [161]. The protective effects of metformin against inflammation and oxidative stress in Günther’s killifish gut following polyinosinic/polycytidylic acid (poly I/C)-induced aging-like phenomena were studied. Metformin treatment attenuates gut aging by reducing inflammation and oxidative stress and enhancing mitochondrial function. Metformin activates AMPK signaling, contributing to anti-aging effects through NAD+-dependent pathways. These results suggest that metformin can counteract age-related gut dysfunction by mitigating inflammation and oxidative damage [162]. Another study revealed a novel immunoregulatory role of SIRT6 in antiviral defense mechanisms in Chinese perch (Siniperca chuatsi), demonstrating NAD+-dependent regulation of the host antiviral response. SIRT6 enhances interferon-stimulated gene expression and promotes antiviral immunity through RIG-I–like receptor signaling. Viral infections increase cellular NAD+ levels, suggesting a new link between NAD+ metabolism and innate immunity in vertebrates. These results showed that SIRT6, an NAD+-sensing protein, plays a crucial role in antiviral defense in fish, highlighting its therapeutic applications in aquaculture. This study advances our understanding of the SIRT-mediated immunity in vertebrates [163].
A transcriptomic analysis of a parasite-resistant grouper hybrid (Epinephelus fuscogutatus × E. lanceolatus) was performed to elucidate the innate immune mechanisms underlying resistance. A differential expression of genes involved in immune signaling, inflammation, and oxidative stress responses was observed. Genes associated with NAD+-dependent enzymes and redox balance were implicated, showing NAD’s role in modulating metabolism and immune function during pathogen defense in fish. This indicates that NAD-related pathways contribute to the immune resilience against parasites [164].
These findings collectively underscore the fundamental significance of NAD+ metabolism in fish biology, encompassing cellular energy production and complex physiological processes such as immune function and environmental adaptation. All these results indicate the potential of targeting NAD+-related pathways in aquaculture and fish health management strategies.
Table 7. NAD+ related metabolic pathways in fish infection, immunity, and therapy.
Table 7. NAD+ related metabolic pathways in fish infection, immunity, and therapy.
Fish SpeciesContextKey FindingsReference
Coral trout
(Plectropomus leopardus)
Bacterial infection
(Vibrio sp.)
Metabolomic profiling revealed alterations in NAD+-dependent pathways, affecting redox balance and energy metabolism[156]
Large yellow croakers (Pseudosciaena crocea)Aptamers and bacterial infection (Pseudomonas plecoglossicida)Aptamer B4 inhibits pathogen; transcriptomic shifts involve NAD+/NADH redox reactions; potential therapeutic targets in NAD-dependent processes[159]
Grass carp (Ctenopharyngodon idella)Viral infection (IRF9, interferon regulator factor 9)IRF9 inhibits SIRT1, enhances p53 acetylation and apoptosis; demonstrates a trade-off between metabolic regulation and immune defense[160]
Killifish
(Nothobranchius guentheri)
Metformin (clinical agent of type 2 diabetes) and poly I/C (viral mimic)Metformin attenuates gut aging via NAD+-dependent AMP-activated protein kinase activation; reduces inflammation, oxidative stress, and enhances mitochondrial function[162]
Chinese perch
(Siniperca chuatsi)
Sirtuin 6 (SIRT6) in antiviral defense
(Siniperhavirus chuatsi)
SIRT6 enhances interferon-stimulated genes; viral infections increase NAD+; highlights SIRT6 role in NAD+-dependent antiviral defense[163]
Grouper hybrid (Epinephelus fuscogutatus × Epinephelus lanceolatus)Parasite resistance
(Cryptocaryon irritans)
Transcriptomic analysis revealed NAD+-dependent enzymes involved in immune signaling and redox balance, contributing to parasite resistance[164]

9. NAD+ Influence in Fish Eggs and Declining in Muscle Post Mortem

Different enzymes related to NAD+ metabolism have been studied in fish eggs and post mortem muscle. In both cases, the same idea was used to determine the fundamental enzymatic principles that could be investigated in both systems. Both are highly useful, albeit very different, model systems for understanding enzyme kinetics, regulation, and functions under specific conditions.
Enzymatic activities within eggs have been proposed as indicators of quality. The measurement of biochemical components, such as the NADH/NAD ratio and egg respiration rate, provided reliable insights into the viability of lake trout (Salmo trutta lacustris) eggs [165]. The potential application of these parameters for predicting egg quality during short-term (4 h) storage was examined. The studied species included common carp, silver carp (Hypophthalmichthys molitrix), grass carp, and bleak (Chalcalburnus chalcoides). Many changes were observed in the eggs, although their biochemical composition and enzymatic activities remained unchanged. The parameters examined for their correlation with fertilization rate included egg enzyme activities crucial for energy metabolism (such as NAD-dependent malate dehydrogenase) and biosynthetic processes NADP-dependent isocitrate dehydrogenase) [166].
An investigation examined the influence of factors such as nucleoside triphosphates, inorganic salts, NADH, catecholamines, and oxygen saturation on nitrite-induced oxidation of rainbow trout hemoglobin (Hb). NADH acts as a reducing agent, affecting hemoglobin’s oxidative state. NADH is important in modulating hemoglobin’s vulnerability to nitrite-induced oxidation, which is essential for oxygen transport and preventing methemoglobin formation in fish [167]. Physiological studies have demonstrated that hypoxia-tolerant species, such as carp, employ NADH-dependent mechanisms to preserve Hb functionality under oxygen-limited conditions [168], whereas Antarctic fish have evolved enhanced Hb redox stability as an adaptation to extreme environments [169]. The redox behavior of fish hemoproteins, such as myoglobin (Mb) and Hb, is crucial for both physiological adaptations and post mortem seafood quality. A review provides significant insights from both foundational and recent research to clarify the distinct redox characteristics of fish hemoproteins and their practical applications. Expanding on the foundational research by Brown and Snyder regarding NADH/flavin-driven redox processes in mammalian hemoproteins [170], different studies have demonstrated that fish Mb undergoes unique oxidation processes that occur two to three times faster than those in mammals. This significantly affects the color stability in species such as sardine (Sardinella gibbosa) and mackerel (Rastrelliger kanagurta) [171]. The NADH-cytochrome b5 reductase system has been identified as crucial for maintaining Mb in its reduced state in tuna muscle, thereby directly impacting shelf life and visual quality [172]. These fundamental insights have driven innovations in seafood preservation, including the development of CO-treated tuna products that reduce metmyoglobin formation by 60% [173], and optimized freezing protocols to minimize oxidation in mackerel, highlighting the need for rapid freezing and antioxidant treatments to preserve fish quality [174].
Reduction in NAD+ and NADH levels following death has been associated with muscle breakdown and a decline in the quality of stored fish. The crucial importance of NAD+ in sustaining cellular energy and redox equilibrium has been indicated. NMR spectroscopy was employed to monitor biochemical alterations in the muscle of Atlantic salmon post mortem at various storage temperatures. After death, a decrease in NAD+ and its reduced counterpart, NADH, disrupts cellular energy metabolism, resulting in changes in glycolysis and oxidative processes. The research underscores how shifts in NAD+ metabolism contribute to muscle deterioration and quality degradation in stored fish, emphasizing the vital role of NAD+ in preserving cellular energy and redox balance, even after death [175]. Collectively, these studies bridge molecular redox chemistry with ecological adaptation and food technology, offering a deeper understanding of fish physiology and actionable strategies in the seafood industry. The integration of these findings presents new opportunities for optimizing aquaculture practices, improving seafood preservation methods, and understanding evolutionary adaptations in aquatic vertebrates.

10. Concluding Remarks and Future Research

Several key conclusions emerge from this review. NAD+ homeostasis is integral to fish physiology, affecting energy metabolism, oxidative stress responses, and cellular signaling. NAD+ depletion has been linked to pathological conditions in fish, paralleling observations in mammals, suggesting conserved vertebrate mechanisms. Zebrafish models have been crucial in studying NAD+-related pathways and therapeutic interventions. NAD+ metabolism connects to fish responses to environmental stressors, highlighting its role in ecological adaptation. Furthermore, dietary modulation of NAD+ precursors affects fish growth and immunity, offering applications in aquaculture. NAD+-dependent signaling through SIRTs influences fish neurobiology, while NAD+ metabolism impacts fish skin health and pigmentation, affecting both ecological and commercial aspects. NAD+ in immune regulation and host–pathogen interactions in fish is emerging as a critical area of study, with applications in aquaculture disease management. Additionally, NAD+ levels in fish eggs can indicate egg quality, which is crucial for aquaculture and conservation. It has also been demonstrated that post mortem changes in NAD+ affect muscle quality in fish, impacting the seafood industry. Research on NAD+ in fish biology spans molecular mechanisms, ecological adaptations, and commercial applications, showing its importance in aquatic vertebrates. All these evidences underscore the fundamental significance of NAD+ metabolism in fish biology and highlights potential areas for future research and application in various fields related to aquatic sciences and industries.
Further research is necessary to fully understand species-specific variations in NAD+ metabolism and to translate these findings into practical applications in aquaculture, conservation, and seafood technology. Extant research on NAD+-related metabolites in fish accentuates their significance in various physiological processes. NAD can be synthesized via both de novo and salvage pathways, both of which have potential benefits for aquaculture through dietary supplementation to enhance NAD synthesis, although such studies are still in the nascent stages. Strategies to augment NAD+ synthesis include supplementation with NAD+ precursors (e.g., NAM, NA, NR, and NMN), stimulation of NAD+ synthesis enzymes (such as NAMPT), and activation of NQO1. To avert NAD+ depletion, inhibiting NAD+-consuming enzymes (e.g., SIRTs, PARP-1, and CD38) is also feasible. These strategies warrant further exploration in fish to ascertain their efficacy under various conditions. The optimal dosage for each species, timing of administration of possible supplements, long-term effects, and many other factors remain undetermined.
The restoration of NAD+ levels, which enhances mitochondrial function and protects animal models, presents a promising strategy for mitigating adverse conditions in farmed fish production, including stress and unfavorable environments. Strategies to boost NAD+ concentrations, which decrease in pathological conditions causing economic challenges, are of interest.
Studies have focused on appetite regulation, enhancing our understanding of feeding behavior in aquaculture. These findings suggest SIRT-mediated metabolic adaptation may link peripheral energy status with central appetite pathways in fish. Little attention has been devoted to the effects of NAD+ metabolism. Understanding skin pigmentation is vital for farmed fish production, with NAD+ and SIRTs implicated in this process, though research remains scarce.
Research findings suggest SIRTs function as metabolic coordinators of stress responses, serving as molecular hubs in environmental adaptation by linking metabolic and stress response systems in fish. Augmenting NAD+ levels enhances metabolic resilience under stress. PPARα activation can mitigate diet-induced metabolic issues in marine fish through SIRT1 synergy, offering potential therapeutic strategies. SIRT1 regulates energy balance and maintains redox stability in economically significant fish species. Given marine fish’s unique sensory characteristics and diversity, further study of NAD+ metabolism’s influence on sensory systems and central nervous system interactions is recommended.
Additionally, the fish by-products analyzed were always rich in niacin (vitamin B3) precursors, amino acids such as Try, and high-quality proteins, all of which contribute to NAD+ biosynthesis through both de novo and salvage pathways. Utilizing these by-products in aquafeeds or functional foods could help sustain NAD+ levels in both fish and humans, supporting metabolic health, resistance to oxidative stress, and cellular energy production.
There is still research to be conducted on the involvement of NAD+ metabolism in various fields of interest, such as reproduction, growth, and metamorphosis in fish. There are multiple reasons to study the molecules involved in NAD metabolism in fish, to improve our understanding of these animals’ physiological responses and to develop new strategies to optimize their health and production.

Author Contributions

Conceptualization, M.Á.E. and Á.S.-F.; formal analysis, M.Á.E. and Á.S.-F.; writing—original draft preparation, M.Á.E.; writing—review and editing, M.Á.E. and Á.S.-F. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financed by the project FleshNADs of the ThinkInAzul program supported by MCIN with funding from European Union Next Generation EU (PRTR-C17.I1) and by the Comunidad Autónoma de la Región de Murcia-Fundación Séneca (Spain) and by a National Spanish project financed by the Ministry of Science, Research and Universities MICIU/AEI (grant numbers PID2023-147560OA-I0 and PID2024-156529NB-I00).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

No new data were created.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Katsyuba, E.; Romani, M.; Hofer, D.; Auwerx, J. NAD+ homeostasis in health and disease. Nat. Metab. 2020, 2, 9–31. [Google Scholar] [CrossRef] [PubMed]
  2. Houtkooper, R.H.; Cantó, C.; Wanders, R.J.; Auwerx, J. The secret life of NAD+ is an old metabolite that controls new metabolic signaling pathways. Endocr. Rev. 2010, 31, 194–223. [Google Scholar] [CrossRef] [PubMed]
  3. Davila, A.; Liu, L.; Chellappa, K.; Redpath, P.; Nakamaru-Ogiso, E.; Paolella, L.M.; Zhang, Z.; Migaud, M.E.; Rabinowitz, J.D.; Baur, J.A. Nicotinamide adenine dinucleotide is transported into the mammalian mitochondria. eLife 2018, 7, e33246. [Google Scholar] [CrossRef]
  4. Cantarow, W.; Stollar, B.D. Nicotinamide mononucleotide adenylyltransferase, a non-histone chromatin protein. Arch. Biochem. Biophys. 1977, 180, 34–40. [Google Scholar] [CrossRef]
  5. Lau, C.; Niere, M.; Ziegler, M. The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front. Biosci. 2009, 14, 410–431. [Google Scholar] [CrossRef]
  6. Su, M.; Qiu, F.; Li, Y.; Che, T.; Li, N.; Zhang, S. Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function. Front. Cell Dev. Biol. 2024, 12, 1464815. [Google Scholar] [CrossRef]
  7. Shahgaldi, S.; Kahmini, F.R. A comprehensive review of sirtuins: With a major focus on redox homeostasis and metabolism. Life Sci. 2021, 282, 119803. [Google Scholar] [CrossRef]
  8. Houtkooper, R.H.; Pirinen, E.; Auwerx, J. Sirtuins regulate metabolism and health. Nat. Rev. Mol. Cell Biol. 2012, 13, 225–238. [Google Scholar] [CrossRef]
  9. Tannous, C.; Booz, G.W.; Altara, R.; Muhieddine, D.H.; Mericskay, M.; Refaat, M.M.; Zouein, F.A. Nicotinamide adenine dinucleotide: Biosynthesis, consumption, and therapeutic roles in cardiac diseases. Acta Physiol. 2021, 231, e13551. [Google Scholar] [CrossRef]
  10. Gariani, K.; Menzies, K.J.; Ryu, D.; Wegner, C.J.; Wang, X.; Ropelle, E.R.; Moullan, N.; Zhang, H.; Perino, A.; Lemos, V.; et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 2016, 63, 1190–1204. [Google Scholar] [CrossRef] [PubMed]
  11. Asher, G.; Reinke, H.; Altmeyer, M.; Gutierrez-Arcelus, M.; Hottiger, M.O.; Schibler, U. Poly (ADP-ribose) polymerase 1 participates in phase entrainment of circadian clocks during feeding. Cell 2010, 142, 943–953. [Google Scholar] [CrossRef]
  12. Abbas, K.; Sharf, R.; Alam, M.; Sharf, Y.; Usmani, N. Chronotherapeutic and epigenetic regulation of circadian rhythms: Nicotinamide adenine dinucleotide-sirtuin axis. J. Sleep Med. 2024, 21, 127–133. [Google Scholar] [CrossRef]
  13. Araki, T.; Sasaki, Y.; Milbrandt, J. Increased nuclear NAD biosynthesis and SIRT1 activation prevented axonal degeneration. Science 2004, 305, 1010–1013. [Google Scholar] [CrossRef]
  14. Yang, Y.; Mohammed, F.S.; Zhang, N.; Sauve, A.A. Dihydronicotinamide riboside is a potent NAD+ concentration enhancer both in vitro and in vivo. J. Biol. Chem. 2019, 294, 9295–9307. [Google Scholar] [CrossRef]
  15. Bian, C.; Zhang, C.; Luo, T.; Vyas, A.; Chen, S.H.; Liu, C.; Kassab, M.A.; Yang, Y.; Kong, M.; Yu, X. NADP+ is an endogenous PARP inhibitor involved in DNA damage response and tumor suppression. Nat. Commun. 2019, 10, 693. [Google Scholar] [CrossRef]
  16. Katsyuba, E.; Mottis, A.; Zietak, M.; De Franco, F.; van der Velpen, V.; Gariani, K.; Ryu, D.; Cialabrini, L.; Matilainen, O.; Liscio, P.; et al. De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature 2018, 563, 354–359. [Google Scholar] [CrossRef] [PubMed]
  17. Canto, C.; Houtkooper, R.H.; Pirinen, E.; Youn, D.Y.; Oosterveer, M.H.; Cen, Y.; Fernandez-Marcos, P.J.; Yamamoto, H.; Andreux, P.A.; Cettour-Rose, P.; et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012, 15, 838–847. [Google Scholar] [CrossRef] [PubMed]
  18. Liu, D.; Pitta, M.; Jiang, H.; Lee, J.H.; Zhang, G.; Chen, X.; Kawamoto, E.M.; Mattson, M.P. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: Evidence for improved neuronal bioenergetics and autophagy progression. Neurobiol. Aging 2013, 34, 1564–1580. [Google Scholar] [CrossRef] [PubMed]
  19. Yamamoto, T.; Byun, J.; Zhai, P.; Ikeda, Y.; Oka, S.; Sadoshima, J. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS ONE 2014, 9, e98972. [Google Scholar] [CrossRef]
  20. Khan, N.A.; Auranen, M.; Paetau, I.; Pirinen, E.; Euro, L.; Forsström, S.; Pasila, L.; Velagapudi, V.; Carroll, C.J.; Auwerx, J.; et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside and vitamin B3. EMBO Mol. Med. 2014, 6, 721–731. [Google Scholar] [CrossRef]
  21. Morigi, M.; Perico, L.; Rota, C.; Longaretti, L.; Conti, S.; Rottoli, D.; Novelli, R.; Remuzzi, G.; Benigni, A. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J. Clin. Investig. 2015, 125, 715–726. [Google Scholar] [CrossRef]
  22. Verdin, E. NAD+ in aging, metabolism, and neurodegeneration. Science 2015, 350, 1208–1213. [Google Scholar] [CrossRef] [PubMed]
  23. Amjad, S.; Nisar, S.; Bhat, A.A.; Shah, A.R.; Frenneaux, M.P.; Fakhro, K.; Haris, M.; Reddy, R.; Patay, Z.; Baur, J.; et al. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol. Metab. 2021, 49, 101195. [Google Scholar] [CrossRef] [PubMed]
  24. Yang, S.J.; Choi, J.M.; Kim, L.; Park, S.E.; Rhee, E.J.; Lee, W.Y.; Oh, K.W.; Park, S.W.; Park, C.Y. Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. J. Nutr. Biochem. 2014, 25, 66–72. [Google Scholar] [CrossRef] [PubMed]
  25. Canto, C. NAD+ Precursors: A questionable redundancy. Metabolites 2022, 12, 630. [Google Scholar] [CrossRef]
  26. Trammell, S.A.J.; Schmidt, M.S.; Weidemann, B.J.; Redpath, P.; Jaksch, F.; Dellinger, R.W.; Li, Z.; Abel, E.D.; Migaud, M.E.; Brenner, C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 2016, 7, 12948. [Google Scholar] [CrossRef] [PubMed]
  27. Alegre, G.F.S.; Pastore, G.M. NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), are potential dietary contributors to health. Curr. Nutr. Rep. 2023, 12, 445–464. [Google Scholar] [CrossRef] [PubMed]
  28. Elhassan, Y.S.; Kluckova, K.; Fletcher, R.S.; Schmidt, M.S.; Garten, A.; Doig, C.L.; Cartwright, D.M.; Oakey, L.; Burley, C.V.; Jenkinson, N.; et al. Nicotinamide riboside augments the human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures in aged subjects: A placebo-controlled, randomized trial. Cell Rep. 2019, 28, 1717–1728. [Google Scholar] [CrossRef] [PubMed]
  29. Dollerup, O.L.; Christensen, B.; Svart, M.; Schmidt, M.S.; Sulek, K.; Ringgaard, S.; Stødkilde-Jørgensen, H.; Møller, N.; Brenner, C.; Treebak, J.T.; et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: Safety, insulin sensitivity, and lipid-mobilizing effects. Am. J. Clin. Nutr. 2018, 108, 343–353. [Google Scholar] [CrossRef]
  30. Obrador, E.; Salvador-Palmer, R.; Pellicer, B.; López-Blanch, R.; Sirerol, J.A.; Villaescusa, J.I.; Montoro, A.; Dellinger, R.W.; Estrela, J.M. The combination of natural polyphenols with a precursor of NAD+ and a TLR2/6 ligand lipopeptide protects mice against lethal γ-radiation. J. Adv. Res. 2023, 45, 73–86. [Google Scholar] [CrossRef] [PubMed]
  31. Espinoza, S.E.; Khosla, S.; Baur, J.A.; de Cabo, R.; Musi, N. Drugs targeting mechanisms of aging to delay age-related disease and promote health span: Proceedings of a National Institute on Aging Workshop. J. Gerontol. A Biol. Sci. Med. Sci. 2023, 78, 53–60. [Google Scholar] [CrossRef]
  32. Yang, X.; Lu, A.; Guan, X.; Ying, T.; Pan, J.; Tan, M.; Lu, J. An updated review on the mechanisms, pre-clinical and clinical comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR). Food Front. 2024, 6, 630–643. [Google Scholar] [CrossRef]
  33. Schlegel, A.; Stainier, D.Y.R. Lessons from “lower” organisms: What worms, flies, and zebrafish can teach us about human energy metabolism. PLoS Genet. 2007, 3, e199. [Google Scholar] [CrossRef]
  34. Prisingkorn, W.; Prathomya, P.; Jakovlic, I.; Liu, H.; Zhao, Y.H.; Wang, W.M. Transcriptomics, metabolomics and histology indicate that high-carbohydrate diet negatively affects the liver health of blunt snout bream (Megalobrama amblycephala). BMC Genom. 2017, 18, 856. [Google Scholar] [CrossRef] [PubMed]
  35. Kamel, M.; Ninov, N. Catching new targets in metabolic disease with a zebrafish. Curr. Opin. Pharm. 2017, 37, 41–50. [Google Scholar] [CrossRef] [PubMed]
  36. Zang, L.; Maddison, L.A.; Chen, W. Zebrafish as a model for obesity and diabetes. Front. Cell Dev. Biol. 2018, 6, 91. [Google Scholar] [CrossRef] [PubMed]
  37. Asaoka, Y.; Terai, S.; Sakaida, I.; Nishina, H. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis. Model. Mech. 2013, 6, 905–914. [Google Scholar] [CrossRef]
  38. Oka, T.; Nishimura, Y.; Zang, L.; Hirano, M.; Shimada, Y.; Wang, Z.; Umemoto, N.; Kuroyanagi, J.; Nishimura, N.; Tanaka, T. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 2010, 10, 21. [Google Scholar] [CrossRef]
  39. Goody, M.F.; Kelly, M.W.; Lessard, K.N.; Khalil, A.; Henry, C.A. Nrk2b-mediated NAD+ production regulates cell adhesion and is required for muscle morphogenesis in vivo: Nrk2b and NAD+ in muscle morphogenesis. Dev. Biol. 2010, 344, 809–826. [Google Scholar] [CrossRef]
  40. Goody, M.F.; Henry, C.A. A need for NAD+ in muscle development, homeostasis, and aging. Skelet. Muscle 2018, 8, 9. [Google Scholar] [CrossRef]
  41. Goody, M.F.; Kelly, M.W.; Reynolds, C.J.; Khalil, A.; Crawford, B.D.; Henry, C.A. NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy. PLoS Biol. 2012, 10, e1001409. [Google Scholar] [CrossRef]
  42. Ran, G.; Ying, L.; Li, L.; Yan, Q.; Yi, W.; Ying, C.; Wu, H.; Ye, X. Resveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio rerio). PLoS ONE 2017, 12, e0180865. [Google Scholar] [CrossRef] [PubMed]
  43. Schneider, A.C.; Gregório, C.; Uribe-Cruz, C.; Guizzo, R.; Malysz, T.; Faccioni-Heuser, M.C.; Longo, L.; da Silveira, T.R. Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver. World J. Hepatol. 2017, 9, 418–426. [Google Scholar] [CrossRef] [PubMed]
  44. Park, K.H.; Kim, S.H. Adult zebrafish as an in vivo drug-testing model for ethanol-induced acute hepatic injury. Biomed. Pharmacother. 2020, 132, 110836. [Google Scholar] [CrossRef] [PubMed]
  45. Martínez-Morcillo, F.J.; Cantón-Sandoval, J.; Martínez-Navarro, F.J.; Cabas, I.; Martínez-Vicente, I.; Armistead, J.; Hatzold, J.; López-Muñoz, A.; Martínez-Menchón, T.; Corbalán-Vélez, R.; et al. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation via parthanatos. PLoS Biol. 2021, 19, e3001455. [Google Scholar] [CrossRef]
  46. Ding, Q.; Zhang, Z.; Li, Y.; Liu, H.; Hao, Q.; Yang, Y.; Ringø, E.; Olsen, R.E.; Clarke, J.L.; Ran, C.; et al. Propionate induces intestinal oxidative stress via Sod2 propionylation in zebrafish. iScience 2021, 24, 102515. [Google Scholar] [CrossRef]
  47. Zhang, D.; Zhao, L.; Wong, L. β-Nicotinamide mononucleotide supplement with astaxanthin and blood orange enhanced NAD+ bioavailability and mitigated age-associated physiological decline in zebrafish. Curr. Dev. Nutr. 2022, 6, 54. [Google Scholar] [CrossRef]
  48. Yang, L.; Zhu, B.; Zhou, S.; Zhao, M.; Li, R.; Zhou, Y.; Shi, X.; Han, J.; Zhang, W.; Zhou, B. Mitochondrial dysfunction is involved in decabromodiphenyl ethane-induced lipid metabolism disorders and neurotoxicity in zebrafish larvae. Environ. Sci. Technol. 2023, 57, 11043–11055. [Google Scholar] [CrossRef]
  49. Pandaram, A.; Paul, J.; Wankhar, W.; Thakur, A.; Verma, S.; Vasudevan, K.; Wankhar, D.; Kammala, A.K.; Sharma, P.; Jaganathan, R.; et al. Aspartame causes developmental defects and teratogenicity in zebrafish embryo: Role of impaired SIRT1/FOXO3a axis in neuron cells. Biomedicines 2024, 12, 855. [Google Scholar] [CrossRef] [PubMed]
  50. Tsurho, V.; Gilliland, C.; Ensing, J.; Vansickle, E.; Lanning, N.J.; Mark, P.R.; Grainger, S. A zebrafish model of nicotinamide adenine dinucleotide (NAD+) deficiency-derived congenital disorders. Dev. Biol. 2025, 529, 2771–2777. [Google Scholar] [CrossRef]
  51. Xu, H.; Mao, X.; Zhang, S.; Ren, J.; Jiang, S.; Cai, L.; Miao, X.; Tao, Y.; Peng, C.; Lv, M.; et al. Perfluorooctanoic acid triggers premature ovarian insufficiency by impairing NAD+ synthesis and mitochondrial function in adult zebrafish. Toxicol. Sci. 2024, 201, 118–128. [Google Scholar] [CrossRef] [PubMed]
  52. Wan, Y.; Li, J.; Guo, Y.; Guo, F.; Zhao, Y.; Li, Y.; Yang, X.; Chen, H.; Xie, S.; Wang, M.; et al. Identification and functional characterization of a novel PRPS1 variant in X-linked nonsyndromic hearing loss: Insights from zebrafish and cellular models. Hum. Mutat. 2025, 2025, 6690588. [Google Scholar] [CrossRef]
  53. Luo, Q.; Yang, Y.; Xian, C.; Zhou, P.; Zhang, H.; Lv, Z.; Liu, J. Nicotinamide riboside ameliorates survival time and motor dysfunction in an MPTP-Induced Parkinson’s disease zebrafish model through effects on glucose metabolism and endoplasmic reticulum stress. Chem. Biol. Interact. 2024, 399, 111118. [Google Scholar] [CrossRef]
  54. Raas, Q.; Haouy, G.; de Calbiac, H.; Pasho, E.; Marian, A.; Guerrera, I.C.; Rosello, M.; Oeckl, P.; Del Bene, F.; Catanese, A.; et al. TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish models. Cell Death Discov. 2025, 11, 98. [Google Scholar] [CrossRef]
  55. Shimeno, S.; Saida, Y.; Tabata, T. Response of hepatic NAD- and NADP-isocitrate dehydrogenase activities to several dietary conditions in fishes. Nippon Suisan Gakkaishi 1996, 62, 642–648. [Google Scholar] [CrossRef]
  56. Carafa, V.; Rotili, D.; Forgione, M.; Cuomo, F.; Serretiello, E.; Hailu, G.S.; Jarho, E.; Lahtela-Kakkonen, M.; Mai, A.; Altucci, L. Sirtuin functions and modulation: From chemistry to the clinic. Clin. Epigenetics 2016, 8, 61. [Google Scholar] [CrossRef]
  57. Kabiljo, J.; Murko, C.; Pusch, O.; Zupkovitz, G. Spatio-temporal expression profile of sirtuins during aging of the annual fish Nothobranchius furzeri. Gene Expr. Patterns 2019, 33, 11–19. [Google Scholar] [CrossRef] [PubMed]
  58. Liu, J.; Jia, E.; Shi, H.; Li, X.; Jiang, G.; Chi, C.; Liu, W.; Zhang, D. Selection of reference genes for miRNA quantitative PCR and its application in miR-34a/Sirtuin-1 mediated energy metabolism in Megalobrama amblycephala. Fish Physiol. Biochem. 2019, 45, 1663–1681. [Google Scholar] [CrossRef] [PubMed]
  59. Simó-Mirabet, P.; Perera, E.; Calduch-Giner, J.A.; Pérez-Sánchez, J. Local DNA methylation helps to regulate muscle sirtuin 1 gene expression across seasons and advancing age in gilthead sea bream (Sparus aurata). Front. Zool. 2020, 17, 15. [Google Scholar] [CrossRef]
  60. Simó-Mirabet, P.; Naya-Català, F.; Calduch-Giner, J.A.; Pérez-Sánchez, J. The expansion of sirtuin gene family in gilthead sea bream (Sparus aurata). Phylogenetic, syntenic, and functional insights across the vertebrate/fish lineage. Int. J. Mol. Sci. 2024, 25, 6273. [Google Scholar] [CrossRef]
  61. Peng, J.; Zou, J.; Zhao, J.; Chen, A. Genome-wide identification and expression analysis of the SIRT gene family in Nile tilapia (Oreochromis niloticus). Comp. Biochem. Physiol. Part D Genom. Proteom. 2025, 54, 101425. [Google Scholar] [CrossRef]
  62. Liu, Q.; Qi, Y.; Liang, Q.; Xu, X.; Hu, F.; Wang, J.; Xiao, J.; Wang, S.; Li, W.; Tao, M.; et al. The chimeric genes in the hybrid lineage of Carassius auratus cuvieri (♀) × Carassius auratus red var. (♂). Sci. China Life Sci. 2018, 6, 1079–1089. [Google Scholar] [CrossRef] [PubMed]
  63. Tang, Y.; Liu, X.; Feng, C.; Zhou, Z.; Liu, S. Nicotinamide phosphoribosyl transferase (Nampt) of hybrid crucian carp protects intestinal barrier and enhances host immune defense against bacterial infection. Dev. Comp. Immunol. 2022, 128, 104314. [Google Scholar] [CrossRef]
  64. Butler, M.J.; Volkoff, H. The role of visfatin/NAMPT in the regulation of feeding in goldfish (Carassius auratus). Peptides 2023, 160, 170919. [Google Scholar] [CrossRef] [PubMed]
  65. Velasco, C.; Librán-Pérez, M.; Otero-Rodiño, C.; López-Patiño, M.A.; Míguez, J.M.; Soengas, J.L. Ceramides are involved in the regulation of food intake in rainbow trout (Oncorhynchus mykiss). Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016, 311, R658–R668. [Google Scholar] [CrossRef]
  66. Vinnicombe, K.R.T.; Volkoff, H. Possible role of transcription factors (BSX, NKX2.1, IRX3 and SIRT1) in the regulation of appetite in goldfish (Carassius auratus). Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2022, 268, 111189. [Google Scholar] [CrossRef]
  67. Fuentes, E.N.; Zuloaga, R.; Nardocci, G.; Fernandez de la Reguera, C.; Simonet, N.; Fumeron, R.; Valdes, J.A.; Molina, A.; Alvarez, M. Skeletal muscle plasticity induced by seasonal acclimatization in carp involves differential expression of rRNA and molecules that epigenetically regulate its synthesis. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2014, 172–173, 57–66. [Google Scholar] [CrossRef]
  68. Teigen, L.E.; Orczewska, J.I.; McLaughlin, J.; O’Brien, K.M. Cold acclimation increases levels of some heat shock protein and sirtuin isoforms in threespine stickleback. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2015, 188, 139–147. [Google Scholar] [CrossRef]
  69. Ekambaram, P.; Parasuraman, P. Differential expression of sirtuin 2 and adipocyte maturation restriction: An adaptation process during hypoxia in fish. Biol. Open 2017, 6, 1375–1382. [Google Scholar] [CrossRef]
  70. Naderi, F.; Hernández-Pérez, J.; Chivite, M.; Soengas, J.L.; Míguez, J.M.; López-Patiño, M.A. Involvement of cortisol and sirtuin1 during the response to stress of hypothalamic circadian system and food intake-related peptides in rainbow trout, Oncorhynchus mykiss. Chronobiol. Int. 2018, 35, 1122–1141. [Google Scholar] [CrossRef] [PubMed]
  71. Ma, Q.; Kuang, J.; Liu, X.; Li, A.; Feng, W.; Zhuang, Z. Effects of osmotic stress on Na+/K+-ATPase, caspase 3/7 activity, and the expression profiling of sirt1, hsf1, and hsp70 in the roughskin sculpin (Trachidermus fasciatus). Fish Physiol. Biochem. 2020, 46, 135–144. [Google Scholar] [CrossRef]
  72. Qian, L.; Miao, L.; Abba, B.S.A.; Lin, Y.; Jiang, W.; Chen, S.; Luo, C.; Liu, B.; Ge, X. Molecular characterization and expression of sirtuin 2, sirtuin 3, and sirtuin 5 in the Wuchang bream (Megalobrama amblycephala) in response to acute temperature and ammonia nitrogen stress. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2021, 252, 110520. [Google Scholar] [CrossRef] [PubMed]
  73. Li, M.; Hu, J.; Zhou, J.; Wu, C.; Li, D.; Mao, H.; Kong, L.; Hu, C.; Xu, X. Grass carp (Ctenopharyngodon idella) deacetylase SIRT1 targets p53 to suppress apoptosis in a KAT8 dependent or independent manner. Fish Shellfish Immunol. 2024, 144, 109264. [Google Scholar] [CrossRef]
  74. Machala, M.; Dusek, L.; Hilscherová, K.; Kubínová, R.; Jurajda, P.; Neca, J.; Ulrich, R.; Gelnar, M.; Studnicková, Z.; Holoubek, I. Determination and multivariate statistical analysis of biochemical responses to environmental contaminants in feral freshwater fish Leuciscus cephalus L. Environ. Toxicol. Chem. 2001, 20, 1141–1148. [Google Scholar]
  75. Berg, K.; Puntervoll, P.; Klungsøyr, J.; Goksøyr, A. Brain proteome alterations of Atlantic cod (Gadus morhua) exposed to PCB 153. Aquat. Toxicol. 2011, 105, 206–217. [Google Scholar] [CrossRef]
  76. Riar, N.; Crago, J.; Jiang, W.; Maryoung, L.A.; Gan, J.; Schlenk, D. Effects of salinity acclimation on the endocrine disruption and acute toxicity of bifenthrin in freshwater and euryhaline strains of Oncorhynchus mykiss. Environ. Toxicol. Chem. 2013, 32, 2779–2785. [Google Scholar] [CrossRef] [PubMed]
  77. Garattini, E.; Mendel, R.; Romão, M.J.; Wright, R.; Terao, M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: Structure, genetics, regulation, function and pathophysiology. Biochem. J. 2003, 372, 15–32. [Google Scholar] [CrossRef] [PubMed]
  78. Aburas, O.A. Investigation of Aldehyde Oxidase and Xanthine Oxidoreductase in Rainbow Trout (Oncorhynchus mykiss). Doctoral Thesis, University of Huddersfield, Huddersfield, UK, 2014. Available online: http://eprints.hud.ac.uk/id/eprint/23543/ (accessed on 18 November 2025).
  79. Almeida, Â.; Silva, M.G.; Soares, A.M.V.M.; Freitas, R. Concentrations levels and effects of 17alpha-Ethinylestradiol in freshwater and marine waters and bivalves: A review. Environ. Res. 2020, 185, 109316. [Google Scholar] [CrossRef]
  80. Zhou, X.; Li, Y.; Li, H.; Yang, Z.; Zuo, C. Responses in the crucian carp (Carassius auratus) exposed to environmentally relevant concentration of 17α-Ethinylestradiol based on metabolomics. Ecotoxicol. Environ. Saf. 2019, 183, 109501. [Google Scholar] [CrossRef]
  81. Taheri Mirghaed, A.; Baes, M.; Hoseini, S.M. Humoral immune responses and gill antioxidant-related gene expression of common carp (Cyprinus carpio) exposed to lufenuron and flonicamide. Fish Physiol. Biochem. 2020, 46, 739–746. [Google Scholar] [CrossRef]
  82. Jabłońska-Trypuć, A. A review on triclosan in wastewater: Mechanism of action, resistance phenomenon, environmental risks, and sustainable removal techniques. Water Environ. Res. 2023, 95, e10920. [Google Scholar] [CrossRef]
  83. Bao, S.; He, C.; Ku, P.; Xie, M.; Lin, J.; Lu, S.; Nie, X. Effects of triclosan on the RedoximiRs/Sirtuin/Nrf2/ARE signaling pathway in mosquitofish (Gambusia affinis). Aquat. Toxicol. 2021, 230, 105679. [Google Scholar] [CrossRef]
  84. Wu, S.; Zhang, L.; Chen, J. Paracetamol in the environment and its degradation by microorganisms. Appl. Microbiol. Biotechnol. 2012, 96, 875–884. [Google Scholar] [CrossRef]
  85. Meinan, X.; Yimeng, W.; Chao, W.; Tianli, T.; Li, J.; Peng, Y.; Xiangping, N. Response of the Sirtuin/PXR signaling pathway in Mugilogobius chulae exposed to environmentally relevant concentration Paracetamol. Aquat. Toxicol. 2022, 249, 106222. [Google Scholar] [CrossRef]
  86. Vargas, R.; Ponce-Canchihuamán, J. Emerging various environmental threats to brain and overview of surveillance system with zebrafish model. Toxicol. Rep. 2017, 4, 467–473. [Google Scholar] [CrossRef] [PubMed]
  87. Zhao, Y.; Xie, M.; Wang, C.; Wang, Y.; Peng, Y.; Nie, X. Effects of atorvastatin on the Sirtuin/PXR signaling pathway in Mugilogobius chulae. Environ. Sci. Pollut. Res. Int. 2023, 30, 60009–60022. [Google Scholar] [CrossRef] [PubMed]
  88. Iacopetta, D.; Catalano, A.; Ceramella, J.; Saturnino, C.; Salvagno, L.; Ielo, I.; Drommi, D.; Scali, E.; Plutino, M.R.; Rosace, G.; et al. The different facets of triclocarban: A review. Molecules 2021, 26, 2811. [Google Scholar] [CrossRef] [PubMed]
  89. Li, S.; Wang, Y.; Yu, D.; Zhang, Y.; Wang, X.; Shi, M.; Xiao, Y.; Li, X.; Xiao, H.; Chen, L.; et al. Triclocarban evoked neutrophil extracellular trap formation in common carp (Cyprinus carpio L.) by modulating SIRT3-mediated ROS crosstalk with ERK1/2/p38 signaling. Fish Shellfish Immunol. 2022, 129, 85–95. [Google Scholar] [CrossRef]
  90. Magnuson, J.T.; Sydnes, M.O.; Ræder, E.M.; Schlenk, D.; Pampanin, D.M. Transcriptomic profiles of brains in juvenile Atlantic cod (Gadus morhua) exposed to pharmaceuticals and personal care products from a wastewater treatment plant discharge. Sci. Total Environ. 2024, 912, 169110. [Google Scholar] [CrossRef]
  91. Chen, S.; Wang, Y.; Chen, K.; Xing, X.; Jiang, Q.; Xu, T. Unraveling the mechanism of quercetin alleviating BHPF-induced apoptosis in epithelioma papulosum cyprini cells: SIRT3-mediated mitophagy. Fish Shellfish Immunol. 2024, 154, 109907. [Google Scholar] [CrossRef]
  92. Connon, R.E.; Deanovic, L.A.; Fritsch, E.B.; D’Abronzo, L.S.; Werner, I. Sublethal responses to ammonia exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae). Aquat. Toxicol. 2011, 105, 369–377. [Google Scholar] [CrossRef]
  93. Jia, R.; Du, J.; Cao, L.; Feng, W.; He, Q.; Xu, P.; Yin, G. Application of transcriptome analysis to understand the adverse effects of hydrogen peroxide exposure on brain function in common carp (Cyprinus carpio). Environ. Pollut. 2021, 286, 117240. [Google Scholar] [CrossRef]
  94. Berg, K.; Puntervoll, P.; Valdersnes, S.; Goksøyr, A. Responses in the brain proteome of Atlantic cod (Gadus morhua) exposed to methylmercury. Aquat. Toxicol. 2010, 100, 51–65. [Google Scholar] [CrossRef]
  95. Li, H.; Di, G.; Zhang, Y.; Liang, J.; Wang, X.; Xu, Z.; Kong, X. miR-217 through SIRT1 regulates the immunotoxicity of cadmium in Cyprinus carpio. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2021, 248, 109086. [Google Scholar] [CrossRef] [PubMed]
  96. Wei, X.; Hogstrand, C.; Chen, G.; Lv, W.; Song, Y.; Xu, Y.; Luo, Z. Zn Induces lipophagy via the deacetylation of beclin1 and alleviates Cu-induced lipotoxicity at their environmentally relevant concentrations. Environ. Sci. Technol. 2021, 55, 4943–4953. [Google Scholar] [CrossRef] [PubMed]
  97. Hong, H.; Liu, Z.; Li, S.; Wu, D.; Jiang, L.; Li, P.; Wu, Z.; Xu, J.; Jiang, A.; Zhang, Y.; et al. Zinc oxide nanoparticles (ZnO-NPs) exhibit immune toxicity to crucian carp (Cyprinus carpio) by neutrophil extracellular traps (NETs) release and oxidative stress. Fish Shellfish Immunol. 2022, 129, 22–29. [Google Scholar] [CrossRef] [PubMed]
  98. Lall, S.P.; Kaushik, S. Nutrition and metabolism of minerals in fish. Animals 2021, 11, 2711. [Google Scholar] [CrossRef]
  99. Wagemann, R.; Dick, J.G.; Klaverkamp, J.F. Metallothionein estimates in marine mammal and fish tissues by three methods: 203Hg displacement, polarography and metal-Summation. Int. J. Environ. Anal. Chem. 1994, 54, 147–160. [Google Scholar] [CrossRef]
  100. Zhong, C.C.; Zhang, X.; Pantopoulos, K.; Song, C.C.; Yang, H.; Wei, X.L.; Luo, Z. Mitochondrial oxidative stress inhibited Sirt3/Foxo3/PPARα pathway and aggravated copper and zinc co-deficiency-induced hepatic lipotoxicity in a fish model. Cell Mol. Life Sci. 2025, 82, 226. [Google Scholar] [CrossRef]
  101. Wang, M.C.; Wang, Y.C.; Peng, H.W.; Hseu, J.R.; Wu, G.C.; Chang, C.F.; Tseng, Y.C. Resveratrol induces expression of metabolic and antioxidant machinery and protects tilapia under cold stress. Int. J. Mol. Sci. 2020, 21, 3338. [Google Scholar] [CrossRef]
  102. Wu, L.; Chen, Q.; Dong, B.; Han, D.; Zhu, X.; Liu, H.; Yang, Y.; Xie, S.; Jin, J. Resveratrol attenuated oxidative stress and inflammatory and mitochondrial dysfunction induced by acute ammonia exposure in gibel carp (Carassius gibelio). Ecotoxicol. Environ. Saf. 2023, 251, 114544. [Google Scholar] [CrossRef]
  103. Xia, Y.; Li, S.; Wang, X.; Zhao, B.; Chen, S.; Jiang, Q.; Xu, S.; Li, S. Astilbin targeted Sirt1 to inhibit acetylation of Nrf2 to alleviate grass carp hepatocyte apoptosis caused by PCB126-induced mitochondrial kinetic and metabolism dysfunctions. Fish Shellfish Immunol. 2023, 141, 109000. [Google Scholar] [CrossRef]
  104. Otero-Rodiño, C.; Librán-Pérez, M.; Velasco, C.; Álvarez-Otero, R.; López-Patiño, M.A.; Míguez, J.M.; Soengas, J.L. Glucosensing in liver and Brockmann bodies of rainbow trout through glucokinase-independent mechanisms. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2016, 199, 29–42. [Google Scholar] [CrossRef]
  105. Dai, Y.J.; Liu, W.B.; Li, X.F.; Zhou, M.; Xu, C.; Qian, Y.; Jiang, G.Z. Molecular cloning of adipose triglyceride lipase (ATGL) gene from blunt snout bream and its expression after LPS-induced TNF-α factor. Fish Physiol. Biochem. 2018, 44, 1143–1157. [Google Scholar] [CrossRef] [PubMed]
  106. Xu, C.; Liu, W.B.; Remø, S.C.; Wang, B.K.; Shi, H.J.; Zhang, L.; Liu, J.D.; Li, X.F. Feeding restriction alleviates high carbohydrate diet-induced oxidative stress and inflammation of Megalobrama amblycephala by activating the AMPK-SIRT1 pathway. Fish Shellfish Immunol. 2019, 92, 637–648. [Google Scholar] [CrossRef] [PubMed]
  107. Wang, T.; Yang, B.; Ji, R.; Xu, W.; Mai, K.; Ai, Q. Omega-3 polyunsaturated fatty acids alleviate hepatic steatosis-induced inflammation through Sirt1-mediated nuclear translocation of NF-κB p65 subunit in hepatocytes of large yellow croaker (Larmichthys crocea). Fish Shellfish Immunol. 2017, 71, 76–82. [Google Scholar] [CrossRef] [PubMed]
  108. Saha, M.; Dhiman, S.; Gupta, G.D.; Asati, V. An investigative review for pharmaceutical analysis of fenofibrate. J. Chromatogr. Sci. 2023, 61, 494–504. [Google Scholar] [CrossRef]
  109. Jin, M.; Zhu, T.; Tocher, D.R.; Luo, J.; Shen, Y.; Li, X.; Pan, T.; Yuan, Y.; Betancor, M.B.; Jiao, L.; et al. Dietary fenofibrate attenuated high-fat-diet-induced lipid accumulation and inflammation response partly through regulation of pparα and sirt1 in juvenile black seabream (Acanthopagrus schlegelii). Dev. Comp. Immunol. 2020, 109, 103691. [Google Scholar] [CrossRef]
  110. Huang, Y.; Wang, S.; Meng, X.; Chen, N.; Li, S. Molecular cloning and characterization of sirtuin 1 and its potential regulation of lipid metabolism and antioxidant response in largemouth bass (Micropterus salmoides). Front. Physiol. 2021, 12, 726877. [Google Scholar] [CrossRef]
  111. Arumugam, M.K.; Paal, M.C.; Donohue, T.M., Jr.; Ganesan, M.; Osna, N.A.; Kharbanda, K.K. Beneficial effects of betaine: A comprehensive review. Biology 2021, 10, 456. [Google Scholar] [CrossRef]
  112. Jin, M.; Shen, Y.; Pan, T.; Zhu, T.; Li, X.; Xu, F.; Betancor, M.B.; Jiao, L.; Tocher, D.R.; Zhou, Q. Dietary betaine mitigates hepatic steatosis and inflammation induced by a high-fat-diet by modulating the Sirt1/Srebp-1/Pparɑ pathway in juvenile black seabream (Acanthopagrus schlegeli). Front. Immunol. 2021, 12, 694720. [Google Scholar] [CrossRef]
  113. Raymundo, D.P.; Doultsinos, D.; Guillory, X.; Carlesso, A.; Eriksson, L.A.; Chevet, E. Pharmacological targeting of IRE1 in cancer. Trends Cancer 2020, 6, 1018–1030. [Google Scholar] [CrossRef] [PubMed]
  114. Jin, M.; Shen, Y.; Monroig, Ó.; Zhao, W.; Bao, Y.; Zhu, T.; Tocher, D.R.; Zhou, Q. Sirt1 mitigates hepatic lipotoxic injury induced by high-fat-diet in fish through Ire1α deacetylation. J. Nutr. 2024, 154, 3210–3224. [Google Scholar] [CrossRef] [PubMed]
  115. Luthuli, S.; Wu, S.; Cheng, Y.; Zheng, X.; Wu, M.; Tong, H. Therapeutic effects of fucoidan: A review on recent studies. Mar. Drugs 2019, 17, 487. [Google Scholar] [CrossRef]
  116. Zhao, W.; Shen, Y.; Bao, Y.; Monroig, Ó.; Zhu, T.; Sun, P.; Tocher, D.R.; Zhou, Q.; Jin, M. Fucoidan alleviates hepatic lipid deposition by modulating the Perk-Eif2α-Atf4 axis via Sirt1 activation in Acanthopagrus schlegelii. Int. J. Biol. Macromol. 2024, 282, 137266. [Google Scholar] [CrossRef]
  117. Radaelli, G.; Domeneghini, C.; Arrighi, S.; Mascarello, F.; Veggetti, A. Different putative neuromodulators are present in the nerves which distribute to the teleost skeletal muscle. Histol. Histopathol. 1998, 13, 939–947. [Google Scholar] [CrossRef] [PubMed]
  118. Wang, H.; Xu, J.; Lazarovici, P.; Quirion, R.; Zheng, W. cAMP response element-binding protein (CREB): A possible signaling molecule link in the pathophysiology of schizophrenia. Front. Mol. Neurosci. 2018, 11, 255. [Google Scholar] [CrossRef] [PubMed]
  119. Rajan, K.E.; Thangaleela, S.; Balasundaram, C. Spatial learning associated with stimulus response in goldfish Carassius auratus: Relationship to activation of CREB signalling. Fish Physiol. Biochem. 2015, 41, 685–694. [Google Scholar] [CrossRef] [PubMed]
  120. Thangaleela, S.; Shanmugapriya, V.; Mukilan, M.; Radhakrishnan, K.; Rajan, K.E. Alterations in MicroRNA-132/212 expression impairs fear memory in goldfish Carassius auratus. Ann. Neurosci. 2018, 25, 90–97. [Google Scholar] [CrossRef]
  121. Pérez-Sánchez, J.; Simó-Mirabet, P.; Naya-Català, F.; Martos-Sitcha, J.A.; Perera, E.; Bermejo-Nogales, A.; Benedito-Palos, L.; Calduch-Giner, J.A. Somatotropic axis regulation unravels the differential effects of nutritional and environmental factors in growth performance of marine farmed fishes. Front. Endocrinol. 2018, 9, 687. [Google Scholar] [CrossRef]
  122. Anken, R.H.; Rahmann, H. An atlas of the distribution of NADPH-diaphorase in the brain of the highly derived swordtail fish Xiphophorus helleri (Atherinoformes: Teleostei). J. Hirnforsch. 1996, 37, 421–449. [Google Scholar]
  123. Funakoshi, K.; Kadota, T.; Atobe, Y.; Goris, R.C.; Kishida, R. NADPH-diaphorase activity in the vagal afferent pathway of the dogfish, Triakis scyllia. Neurosci. Lett. 1997, 237, 129–132. [Google Scholar] [CrossRef]
  124. Villani, L. Development of NADPH-diaphorase activity in the central nervous system of the cichlid fish, Tilapia mariae. Brain Behav. Evol. 1999, 54, 147–158. [Google Scholar] [CrossRef]
  125. Jadhao, A.G.; Malz, C.R. Nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase activity in the brain of a cichlid fish, with remarkable findings in the entopeduncular nucleus: A histochemical study. J. Chem. Neuroanat. 2004, 27, 75–86. [Google Scholar] [CrossRef]
  126. Giraldez-Perez, R.M.; Gaytan, S.P.; Ruano, D.; Torres, B.; Pasaro, R. Distribution of NADPH-diaphorase and nitric oxide synthase reactivity in the central nervous system of the goldfish (Carassius auratus). J. Chem. Neuroanat. 2008, 35, 12–32. [Google Scholar] [CrossRef]
  127. Funakoshi, K.; Kadota, T.; Atobe, Y.; Nakano, M.; Goris, R.C.; Kishida, R. Nitric oxide synthase in the glossopharyngeal and vagal afferent pathway of a teleost, Takifugu niphobles. The branchial vascular innervation. Cell Tissue Res. 1999, 298, 45–54. [Google Scholar] [CrossRef] [PubMed]
  128. Andrews, C.D.; Payne, J.F.; Rise, M.L. Identification of a gene set to evaluate the potential effects of loud sounds from seismic surveys on the ears of fishes: A study with Salmo salar. J. Fish Biol. 2014, 84, 1793–1819. [Google Scholar] [CrossRef] [PubMed]
  129. Simó-Mirabet, P.; Bermejo-Nogales, A.; Calduch-Giner, J.A.; Pérez-Sánchez, J. Tissue-specific gene expression and fasting regulation of sirtuin family in gilthead sea bream (Sparus aurata). J. Comp. Physiol. B 2017, 187, 153–163. [Google Scholar] [CrossRef] [PubMed]
  130. Jiang, W.; Lin, Y.; Qian, L.; Miao, L.; Liu, B.; Ge, X.; Shen, H. Mulberry leaf meal: A potential feed supplement for juvenile Megalobrama amblycephala “Huahai No. 1”. Fish Shellfish Immunol. 2022, 128, 279–287. [Google Scholar] [CrossRef]
  131. Silva-Marrero, J.I.; Villasante, J.; Rashidpour, A.; Palma, M.; Fàbregas, A.; Almajano, M.P.; Viegas, I.; Jones, J.G.; Miñarro, M.; Ticó, J.R.; et al. The administration of chitosan-tripolyphosphate-DNA nanoparticles to express exogenous SREBP1a enhances conversion of dietary carbohydrates into lipids in the liver of Sparus aurata. Biomolecules 2019, 9, 297. [Google Scholar] [CrossRef]
  132. Xu, C.; Huang, X.P.; Guan, J.F.; Chen, Z.M.; Ma, Y.C.; Xie, D.Z.; Ning, L.J.; Li, Y.Y. Effects of dietary leucine and valine levels on growth performance, glycolipid metabolism and immune response in Tilapia GIFT Oreochromis niloticus. Fish Shellfish Immunol. 2022, 121, 395–403. [Google Scholar] [CrossRef]
  133. Sun, S.S.; Feng, L.; Jiang, W.D.; Liu, Y.; Ren, H.M.; Jin, X.W.; Zhou, X.Q.; Wu, P. Declined flesh quality resulting from niacin deficiency is associated with elevated glycolysis and impaired mitochondrial homeostasis in grass carp (Ctenopharyngodon idella). Food Chem. 2024, 451, 139426. [Google Scholar] [CrossRef]
  134. Kandyliari, A.; Mallouchos, A.; Papandroulakis, N.; Golla, J.P.; Lam, T.T.; Sakellari, A.; Karavoltsos, S.; Vasiliou, V.; Kapsokefalou, M. Nutrient composition and fatty acid and protein profiles of selected fish by-products. Foods 2020, 9, 190. [Google Scholar] [CrossRef]
  135. Xu, C.; Liu, W.B.; Shi, H.J.; Mi, H.F.; Li, X.F. Benfotiamine ameliorates high-carbohydrate diet-induced hepatic oxidative stress, inflammation and apoptosis in Megalobrama amblycephala. Aquacult. Res. 2021, 52, 3174–3185. [Google Scholar] [CrossRef]
  136. Shi, H.J.; Xu, C.; Liu, M.Y.; Wang, B.K.; Liu, W.B.; Chen, D.H.; Zhang, L.; Xu, C.Y.; Li, X.F. Resveratrol improves the energy sensing and glycolipid metabolism of blunt snout bream Megalobrama amblycephala fed high-carbohydrate diets by activating the AMPK-SIRT1-PGC-1 network. Front. Physiol. 2018, 9, 1258. [Google Scholar] [CrossRef]
  137. Dong, Y.; Wang, X.; Wei, L.; Liu, Z.; Chu, X.; Xiong, W.; Liu, W.; Li, X. The effectiveness of four Nicotinamide Adenine Dinucleotide (NAD+) precursors in alleviating the high-glucose-induced damage to hepatocytes in Megalobrama amblycephala: Evidence in NAD+ homeostasis, Sirt1/3 activation, redox defense, inflammatory response, apoptosis, and glucose metabolism. Antioxidants 2024, 13, 385. [Google Scholar] [PubMed]
  138. Wachira, M.N.; Osuga, I.M.; Munguti, J.M.; Ambula, M.K.; Subramanian, S.; Tanga, C.M. Efficiency and improved profitability of insect-based aquafeeds for farming Nile tilapia fish (Oreochromis niloticus L.). Animals 2021, 11, 2599. [Google Scholar] [CrossRef] [PubMed]
  139. Kim, S.Y.; Kwak, K.W.; Park, E.S.; Yoon, H.J.; Kim, Y.S.; Park, K.; Kim, E.; Kim, S.D. Evaluation of subchronic oral dose toxicity of freeze-dried skimmed powder of Zophobas atratus larvae (frpfdZAL) in rats. Foods 2020, 9, 995. [Google Scholar] [CrossRef]
  140. van Broekhoven, S.; Oonincx, D.G.A.B.; van Huis, A.; van Loon, J.J.A. Growth performance and feed conversion efficiency of three edible mealworm species (Coleoptera: Tenebrionidae) on diets composed of organic by-products. J. Insect Physiol. 2015, 73, 1–10. [Google Scholar] [CrossRef]
  141. Hong, H.; Regenstein, J.M.; Luo, Y. The importance of ATP-related compounds for the freshness and flavor of post-mortem fish and shellfish muscle: A review. Crit. Rev. Food Sci. Nutr. 2017, 57, 1787–1798. [Google Scholar] [CrossRef]
  142. Li, Y.; Li, H.; Zhang, G.; Liu, J.; Drolma, D.; Ye, B.; Yang, M. Boosted meat flavor by the metabolomic effects of Nile tilapia dietary inclusion of Zophobas atratus larval meal. Front. Biosci. 2024, 29, 382. [Google Scholar] [CrossRef]
  143. Wang, C.; Sun, D.; Hu, X.; Chen, W.; Zou, C.; Zou, J. Effects of Spirulina platensis as a substitute for fishmeal on the liver of zig-zag eel (Mastacembelus armatus) infected with Aeromonas hydrophila. Comp. Biochem. Physiol. Part D Genom. Proteomics 2025, 56, 101563. [Google Scholar] [CrossRef]
  144. Liu, S.; Zheng, Z.; Ji, S.; Liu, T.; Hou, Y.; Li, S.; Li, G. Resveratrol reduces senescence-associated secretory phenotype by SIRT1/NF-κB pathway in gut of the annual fish Nothobranchius guentheri. Fish Shellfish Immunol. 2018, 80, 473–479. [Google Scholar] [CrossRef]
  145. Zheng, Y.; Shi, Y.; Yang, X.; Gao, J.; Nie, Z.; Xu, G. Effects of resveratrol on lipid metabolism in liver of red tilapia Oreochromis niloticus. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2022, 261, 109408. [Google Scholar] [CrossRef]
  146. Zhu, H.; Li, X.; Qiao, M.; Sun, X.; Li, G. Resveratrol alleviates inflammation and ER stress through SIRT1/NRF2 to delay ovarian aging in a short-lived fish. J. Gerontol. A Biol. Sci. Med. Sci. 2023, 78, 596–602. [Google Scholar] [CrossRef] [PubMed]
  147. Bao, Y.; Shen, Y.; Zhao, W.; Yang, B.; Zhao, X.; Tao, S.; Sun, P.; Monroig, Ó.; Zhou, Q.; Jin, M. Evaluation of the optimum dietary arachidonic acid level and its essentiality for black seabream (Acanthopagrus schlegelii): Based on growth and lipid metabolism. Aquac. Nutr. 2024, 2024, 5589032. [Google Scholar] [CrossRef]
  148. Zhang, H.; Yu, L.; Rahman, A.; Govindharajan, S.; Li, L.; Yu, H.; Waqas, M. Effects of varying dietary concentrations of menadione nicotinamide bisulphite (VK3) on growth performance, muscle composition, liver and muscle menaquinone-4 concentration, and antioxidant capacities of coho salmon (Oncorhynchus kisutch) alevins. Biology 2025, 14, 447. [Google Scholar] [CrossRef] [PubMed]
  149. Wu, S.; Huang, J.; Li, Y.; Liu, Z.; Zhao, L. Integrated analysis of lncRNA and circRNA mediated ceRNA regulatory networks in skin reveals innate immunity differences between wild-type and yellow mutant rainbow trout (Oncorhynchus mykiss). Front. Immunol. 2022, 13, 802731. [Google Scholar] [CrossRef]
  150. Li, X.Q.; Lei, J.; Mao, L.H.; Wang, Q.L.; Xu, F.; Ran, T.; Zhou, Z.H.; He, S. NAMPT and NAPRT, key enzymes in NAD salvage synthesis pathway, are of negative prognostic value in colorectal cancer. Front. Oncol. 2019, 9, 736. [Google Scholar] [CrossRef]
  151. Rajman, L.; Chwalek, K.; Sinclair, D.A. Therapeutic potential of NAD-boosting molecules: The in vivo evidence. Cell. Metab. 2018, 27, 529–547. [Google Scholar] [CrossRef] [PubMed]
  152. Jang, Y.S. Skin transcriptome profiling of the blass bloched rockfish (Sebastes pachycephalus) with different body color patterns. Korean J. Ichthyol. 2020, 32, 117–129. [Google Scholar] [CrossRef]
  153. Protas, M.E.; Patel, N.H. Evolution of coloration patterns. Annu. Rev. Cell Dev. Biol. 2008, 24, 425–446. [Google Scholar] [CrossRef]
  154. Hubbard, J.K.; Uy, J.A.; Hauber, M.E.; Hoekstra, H.E.; Safran, R.J. Vertebrate pigmentation: From underlying genes to adaptive function. Trends Genet. 2010, 26, 231–239. [Google Scholar] [CrossRef]
  155. Lamason, R.L.; Mohideen, M.A.P.; Mest, J.R.; Wong, A.C.; Norton, H.L.; Aros, M.C.; Jurynec, M.J.; Mao, X.; Humphreville, V.R.; Humbert, J.E.; et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 2005, 310, 1782–1786. [Google Scholar] [CrossRef] [PubMed]
  156. Wang, J.; Zhang, J.; Shi, M.; Ma, X.; Chen, S.; Zhou, Q.; Zhu, C. Metabolomic analysis revealed the inflammatory and oxidative stress regulation in response to Vibrio infection in Plectropomus leopardus. J. Fish Biol. 2024, 105, 1694–1702. [Google Scholar] [CrossRef] [PubMed]
  157. Jeddi, I.; Saiz, L. Computational design of single-stranded DNA hairpin aptamers immobilized on a biosensor substrate. Sci. Rep. 2021, 11, 10984. [Google Scholar] [CrossRef] [PubMed]
  158. Yu, Q.; Liu, M.; Wei, S.; Qin, X.; Qin, Q.; Li, P. Research progress and prospects for the use of aptamers in aquaculture biosecurity. Aquaculture 2021, 534, 736257. [Google Scholar] [CrossRef]
  159. Tan, Y.; Lin, X.; Huang, L.; Yan, Q.; Wang, J.; Weng, Q.; Zhengzhang, Y.; Chen, Y.; Ma, Y.; Zheng, J. Transcriptomic analysis of the inhibition mechanisms against Pseudomonas plecoglossicida by antibacterial aptamer B4. Front. Vet. Sci. 2024, 11, 1511234. [Google Scholar] [CrossRef]
  160. Jiang, Z.; Weng, P.; Xu, X.; Li, M.; Li, Y.; Lv, Y.; Chang, K.; Wang, S.; Lin, G.; Hu, C. IRF9 promotes apoptosis and innate immunity by inhibiting SIRT1-p53 axis in fish. Fish Shellfish Immunol. 2020, 103, 220–228. [Google Scholar] [CrossRef]
  161. LaMoia, T.E.; Shulman, G.I. Cellular and molecular mechanisms of metformin action. Endocr. Rev. 2021, 42, 77–96. [Google Scholar] [CrossRef]
  162. Li, S.; Hou, Y.; Liu, K.; Zhu, H.; Qiao, M.; Sun, X.; Li, G. Metformin protects against inflammation, oxidative stress to delay Poly I:C-Induced aging-like phenomena in the gut of an annual fish. J. Gerontol. A. Biol. Sci. Med. Sci. 2022, 77, 276–282. [Google Scholar] [CrossRef] [PubMed]
  163. Wu, X.Y.; Zhang, Z.W.; Chen, S.N.; Pang, A.N.; Peng, X.Y.; Li, N.; Liu, L.H.; Nie, P. SIRT6 positively regulates antiviral response in a bony fish, the Chinese perch Siniperca chuatsi. Fish Shellfish Immunol. 2024, 150, 109662. [Google Scholar] [CrossRef]
  164. Mo, Z.Q.; Wu, H.C.; Hu, Y.T.; Lu, Z.J.; Lai, X.L.; Chen, H.P.; He, Z.C.; Luo, X.C.; Li, Y.W.; Dan, X.M. Transcriptomic analysis reveals innate immune mechanisms of an underlying parasite-resistant grouper hybrid (Epinephelus fuscogutatus × Epinephelus lanceolatus). Fish Shellfish Immunol. 2021, 119, 67–75. [Google Scholar] [CrossRef] [PubMed]
  165. Lahnsteiner, F.; Weismann, T.; Patzner, R.A. Physiological and biochemical parameters for egg quality determination in lake trout, Salmo trutta lacustris. Fish Physiol. Biochem. 1999, 20, 375–388. [Google Scholar] [CrossRef]
  166. Lahnsteiner, F.; Urbanyi, B.; Horvath, A.; Weismann, T. Bio-markers for egg quality determination in cyprinid fish. Aquaculture 2001, 195, 331–352. [Google Scholar] [CrossRef]
  167. Jensen, F.B. Influence of nucleoside triphosphates, inorganic salts, NADH, catecholamines, and oxygen saturation on nitrite-induced oxidation of rainbow trout haemoglobin. Fish Physiol. Biochem. 1993, 12, 111–117. [Google Scholar] [CrossRef] [PubMed]
  168. Jensen, F.B.; Nikinmaa, M.; Weber, R.E. Environmental perturbations of oxygen transport in teleost fishes: Causes, consequences, and compensations. J. Exp. Biol. 1993, 179, 153–166. [Google Scholar]
  169. Cashon, R.E.; Vayda, M.E.; Sidell, B.D. Kinetic characterization of myoglobins from vertebrates with vastly different body temperatures. Comp. Biochem. Physiol. Part B: Biochem. Mol. Biol. 1997, 118, 613–619. [Google Scholar] [CrossRef]
  170. Brown, W.D.; Snyder, H.E. Nonenzymatic reduction and oxidation of myoglobin and hemoglobin by nicotinamide adenine dinucleotides and flavins. J. Biol. Chem. 1969, 244, 6702–6706. [Google Scholar] [CrossRef]
  171. Chaijan, M.; Benjakul, S.; Visessanguan, W.; Faustman, C. Characteristics and gel properties of muscles from sardine (Sardinella gibbosa) and mackerel (Rastrelliger kanagurta) caught in Thailand. Food Chem. 2006, 97, 231–239. [Google Scholar] [CrossRef]
  172. Richards, M.P.; Hultin, H.O. Contributions of blood and blood components to lipid oxidation in fish muscle. J. Agric. Food Chem. 2002, 50, 7413–7419. [Google Scholar] [CrossRef] [PubMed]
  173. Baron, C.P.; Kjærsgård, I.V.H.; Jessen, F.; Jacobsen, C. Protein and lipid oxidation during frozen storage of rainbow trout (Oncorhynchus mykiss). J. Agric. Food Chem. 2007, 55, 8118–8125. [Google Scholar] [CrossRef] [PubMed]
  174. Chowdhury, M.J.; Børresen, T. Effect of freezing on biochemical properties of Atlantic mackerel (Scomber scombrus). J. Aquat. Food Prod. Technol. 1995, 4, 5–24. [Google Scholar]
  175. Shumilina, E.; Ciampa, A.; Capozzi, F.; Rustad, T.; Dikiy, A. NMR approach for monitoring post-mortem changes in Atlantic salmon fillets stored at 0 and 4 °C. Food Chem. 2015, 184, 12–22. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.